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ABSTRACT 
Polyunsaturated lipids are lipids which contain two or more carbon-carbon double bonds in their 
constituent hydrocarbon chains. They also serve as excellent substrates for lipid peroxidation. 
However, the roles of lipid peroxidation and its associated enzymes in organisms lacking 
polyunsaturated fatty acids (PUFA) synthesis remain unclear. In this thesis, we studied 1) the 
function of the cardiolipin (CL) remodeling enzyme CL deacylase 1 (Cld1) in CL peroxidation in 
Saccharomyces cerevisiae (S. cerevisiae) and 2) the significance of pLoxA, a lipoxygenase 
(LOX) in Pseudomonas aeruginosa (P. aeruginosa), in triggering ferroptosis in host bronchial 
epithelial (HBE) cells.  
In the first study, we detected oxidized CL (CLox) and other oxidized PLs (PLox) in both 
Δ12-desaturase-expressing WT and cld1Δ yeast. The higher molar ratio of CLox than other PL 
and the absence of phosphatidylserine oxidation suggested the oxidation events occurred in the 
mitochondria. The loss of cld1 elevated the levels of mono-hydroperoxy-CLs and decreased the 
chronological lifespan, mitochondrial membrane potential, and respiratory capacity of the yeast. 
We also found that CLox is a preferred substrate for Cld1 in vitro compared to non-oxidized CLs. 
These data suggest CL remodeling is required to mitigate CL peroxidation. In the second study, 
we demonstrated pLoxA is required for P. aeruginosa to induce ferroptosis in HBE cells. We 
found that clinical P. aeruginosa isolate-induced ferroptosis correlated significantly with the 
HOW ORGANISMS LACKING OXIDIZABLE LIPIDS UTILIZE LIPID 
PEROXIDATION FOR SIGNALING: 
LIPIDOMICS APPROACH 
Hsiu-Chi Ting, PhD 
University of Pittsburgh, 2019 
 
 v 
amount of pLoxA and its 15LOX activity.We found that pro-ferroptotic lipid signals 15-
hydroperoxy-arachidonoyl phosphatidylethanolamines were elevated in both HBE cells treated 
with P. aeruginosa supernatants and in airway tissues from cystic fibrosis (CF) patients with P. 
aeruginosa. Computational studies showed that the catalytic site of LOX is highly conserved 
among species. The α-helical-lid interaction of pLoxA facilitates AA-PE binding, resembling the 
function of the PE-binding protein (PEBP) in the PEBP-15LOX complex in mammalian cells. 
These data showed that P. aeruginosa hijacks host polyunsaturated PEs to induce ferroptosis in 
the bronchial epithelium.  
For public health significance, the function of CL remodeling in mitigating CL 
peroxidation could contribute to the study of CL remodeling defects in Barth syndrome. The 
pLoxA-driven ferroptosis could be a potential therapeutic target against P. aeruginosa–
associated diseases. 
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1.0  INTRODUCTION  
1.1 OXYGEN AND REACTIVE OXYGEN SPECIES 
Oxygen shapes the evolution of life by way of a double-edged sword. On the one hand, it 
sparked the evolution of aerobic respiration, allowing eukaryotes to generate ATP more 
efficiently than their ancestors that relied entirely on anaerobic respiration [1]. On the other hand, 
reactive oxygen species (ROS) are generated as a consequence when oxygen is reduced by the 
electrons leaking from the mitochondrial electron transport chain. 
ROS, by definition, is a collective term for species derived from oxygen that are more 
reactive than oxygen itself [2]. It includes free radicals such as superoxide and hydroxyl radicals 
and non-radicals such as hydrogen peroxide and organic hydroperoxides [3]. ROS are generated 
endogenously by stepwise reduction of oxygen, which takes place in mitochondria, peroxisomes, 
the cell membrane, and the endoplasmic reticulum [4]. Superoxide anion is the first produced 
ROS from a one-step electron reduction of oxygen. Next, superoxide dismutase 
disproportionates superoxide anion to form hydrogen peroxide. Finally, hydrogen peroxide is 
either entirely reduced to water by a catalase and glutathione peroxidases or transformed into a  
strong oxidant, the hydroxyl radical, in the presence of transition metals [5]. ROS can be utilized 
in redox signaling if the basal level is maintained but toxic if not properly handled. Highly-
reactive ROS attacks DNA [6], proteins [7] and lipids [8], which damages cellular structures and 
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functions. If the damage is unable to be repaired or is irreversible, it eventually leads to cell 
death. 
1.2 UNESTERIFIED PUFA PEROXIDATION 
Polyunsaturated fatty acids (PUFAs) are fatty acids that contain more than one double bond. In 
mammals, de novo biosynthesis of n-9 PUFAs starts from palmitic acid (PA, 16:0). The PA is 
converted into oleic acid (OA, 18:1) and is transformed into n-9 PUFAs via the activities of a 
series of elongases and desaturases. However, mammals are not able to synthesize n-3 and n-6 
PUFAs due to the lack of ∆12- and ∆15-desaturases, which are present in plants. Therefore, 
mammals obtain linoleic acid (LA, 18:2) and α-linolenic acid (ALA, 18:3) from plants for n-3 
and n-6 fatty acid biosynthesis [9]. PUFAs are further incorporated into glycerophospholipids to 
form polyunsaturated PLs, which regulate membrane fluidity [10] and lipid signaling [11].  
Despite the essential roles of PUFAs in cell physiology, PUFAs are the main substrates in 
lipid peroxidation because their bis-allylic hydrogens are easily extracted by oxidants. Lipid 
radicals formed in this step are stabilized by a conjugated dienes structure. The lipid peroxidation 
of PUFAs can be non-enzymatic or enzymatic. Non-enzymatic lipid peroxidation is initiated by 
the presence of oxygen and is facilitated by ferrous iron. Enzymatic lipid peroxidation can be 
catalyzed by lipoxygenases (LOXs)- a family of lipid peroxidation enzymes, which oxidize 
unesterified and esterified PUFAs [12].   
Non-enzymatic unesterified PUFA peroxidation starts from the abstraction of the bis-
allylic hydrogens of PUFAs by oxidants, including hydroperoxyl radicals and hydroxyl radicals. 
Then lipid radicals propagate to react with oxygen to form lipid peroxyl radicals, which abstract 
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hydrogen from other PUFAs to form new lipid radicals and lipid hydroperoxides. This free 
radical chain reaction propagates until two free radicals conjugate each other to terminate the 
reactions. Antioxidants can also terminate the reactions by donating a hydrogen atom to the lipid 
peroxyl radicals [13]. The lipid peroxidation products can be decomposed to form the secondary 
products malondialdehyde (MDA) and 4-hydroxynonenal(4-HNE), which are strong 
electrophiles, and tend to react with protein, leading to oxidative damages and/or protein 
modification [14].  
One of the enzyme groups that catalyzes lipid peroxidation is the LOX group. There are 
six functional LOXs in humans. Among them, 15LOXs are the enzymes which are capable of 
catalyzing both unesterified and esterified PUFA peroxidation. 15LOXs contain three members: 
human 15-lipoxygenase-1 (15LOX1) (mouse leukocyte-type 12LOX) encoded by ALOX15 
(alox15 in mouse), human 15-lipoxygenase-2 (15LOX2) (mouse 8LOX) encoded by ALOX15B 
(alox15b in mouse), and epidermis-type lipoxygenase encoded by ALOXE3 (aloxe3 in mouse). 
The X-ray crystal structure of human 15LOX1 and 15LOX2 showed that they contain two 
domains: a β-barrel domain and a catalytic domain. The β-barrel domain is responsible for 
membrane binding, and the catalytic domain is responsible for the coordination of the catalytic 
iron by His residues and the C-terminus Ile residue. The positional specificity of the oxygenation 
reaction is determined by its fatty acid substrate and the volume of the binding pocket [15, 16]. 
Mechanistically, the activation of ferrous LOXs to ferric LOXs initiates the LOX-
catalyzed oxygenation of fatty acids. First, the bis-allylic hydrogen atom of a PUFA is abstracted as 
a proton, forming a lipid radical, and the resulting electron is tunneled to the ferric iron that is 
reduced to the ferrous iron. Next, the lipid radical is rearranged and stabilized by a conjugated double 
bond. Subsequently, the lipid radical reacts with molecular oxygen to form a lipid peroxyl radical. 
Then, the lipid peroxyl radical is reduced by an electron from the ferrous iron to form a lipid peroxyl 
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anion. In this step, the ferrous iron is re-oxidized to the ferric iron. Finally, the lipid peroxyl anion is 
protonated, creating a lipid hydroperoxide [17].   
The main PUFA substrate of 15LOX1 and 15LOX2 is arachidonic acid (AA) but also 
LA. Human 15LOX1 produces products of 15-HpETE/12-HpETE in a 9:1 ratio, but the 
corresponding ratio in mice is 1:4. Human 15LOX2 produces almost completely 15-HpETE 
whereas mouse 8LOX produces 8-HpETE. Epidermis-type LOX in humans and mice uses 12-
HpETE to generate hepoxilins [18].  
LOXs are also found in plants, fungi, and bacteria [19, 20]. P. aeruginosa expresses 
secreted LOX isoform (pLoxA), which shares 25% and 31% of sequence identity to 15LOX1 
and 15LOX2, respectively. It is structurally different from the mammalian LOXs. A pLoxA 
polypeptide folds into a single domain, which lacks the β-barrel domain that exists in the 
mammalian LOXs. But pLoxA contains a helical lid that regulates the substrate accessibility. 
The substrates binding pocket in pLoxA contains two sub-cavities and a lobby: one sub-cavity 
where catalytic iron is located, which accommodates the sn-1 fatty acid, and another sub-cavity 
that does not have direct access to the catalytic iron, which accommodates the sn-2 fatty acid, 
and the polar head of PLs arrested in the lobby [21]. Non-heme iron is coordinated by His, Asn, 
and Ile residues [21]. The substrate specificity of pLoxA has been reported in different studies. 
In Deschamp’s study the preferred unesterified PUFA substrate is AA, and its main products are 
15-(S)-H(p)ETE and a minute amount of 9-, and 11-H(p)ETE. The reaction with LA generates 
predominantly 13-H(p)ODE and a relatively lesser amount of 9-H(p)ODE [22]. In Banthiya’s 
study, the preferred unesterified PUFA substrate is 8,11,14-eicosatrienoic acid (20:3), and the 
position of oxygenation is at carbon 15. The reaction with LA generates oxygenated products at 
carbon 13 [21].  
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1.3 PHOSPHOLIPID PEROXIDATION 
The mechanistic studies of unesterified lipid peroxidation and its secondary metabolites has been 
intensely studied since the 1940s, but the knowledge of phospholipid peroxidation was still 
limited until the late 1980s due to the limitation of available methodology. The application of 
fast atom bombardment (FAB) and, subsequently, electrospray ionization (ESI) in mass 
spectrometry enabled the analysis of less volatile biomolecules and reduced thermal degradation, 
thus expanding the knowledge of phospholipid peroxidation by structural identification.  
One of the ways to form PLox is by re-esterifying oxidized PUFAs (PUFAox) into PLs 
[23-26]. However, similar to the PUFA peroxidation, polyunsaturated PLs themselves can be the 
targets for lipid peroxidation. Notably, there are three enzymes that are capable of directly 
catalyzing polyunsaturated PL peroxidation:  15LOX1, 15LOX2, and cytochrome C (cyto C).  
The activity of 15LOX1 that generates hydroperoxy PC has been first described in rabbit 
reticulocytes [27], where the products 12- and 15-HpETE-esterified PC were detected [28]. 
Later, the activity of 15LOX1 toward PC was found in cell-free human polymorphonuclear 
leukocytes [29]. Direct oxidation by 15LOX1 forms oxidized phosphatidylethanolamine (PEox) 
containing 15-H(p)ETE in monocytes activated by interleukin-4 and ionophore [30]. In addition, 
human 15LOX2 is another LOX family member which is capable of directly oxidizing various 
AA-PLs to form 15-H(p)ETE-PLs [31, 32]. Recently, we discovered that PE binding protein-1 
(PEBP1), which allosterically facilitates the accommodation of AA-PE at the catalytic site of 
15LOXs [33]. It is also reported that pLoxA exhibits PL oxygenase activity, and PE is the 
preferred substrate. The reaction with 1-palmitoyl-2-linoleoyl-PE preponderantly generates 13-
(S)-H(p)ODE [21, 34]. Recently, one study found that pLoxA preferentially utilizes PE for lipid 
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peroxidation, and its main products were determined to be 15-H(p)ETE- and 15-H(p)ODE-
containing PE in the biological membranes of erythrocytes and cultured lung epithelial cells [35].  
Hydroperoxy-PLs can further transform into other types of oxidized PLs without 
enzymatic participation. First, additional oxidation generates PLox with various functional 
groups, such as hydroperoxides, hydroxides, keto- and epoxy-groups in a variety of 
combinations. Second, via intramolecular cyclization, rearrangement, and oxidation, 
isoprostanes, isolevuglandins, isothroboxanes, and isofurans can be formed. Third, oxidative 
fragmentation generates PLox containing a combination of hydroxyl, carbonyl, carboxyl, and 
furan groups [36, 37].  
1.4 OXIDIZED LIPID SIGNALING IN CELL DEATH 
Both PUFAox and PLox act as signaling molecules: PUFAox are essential lipid mediators, 
which bind to specific GPCRs and mediate inflammatory responses [38]. The secondary 
products of lipid peroxidation malondialdehyde (MDA) and 4-hydroxy-2-nonenal (4-HNE) are 
electrophiles that form adducts with proteins [14]. Oxidized phosphatidylcholines (PCox) 
modulate inflammation, intracellular signaling, blood coagulation, platelets activation, vascular 
smooth muscle phenotype, angiogenic activities, and cell adhesion [36, 39]. Additionally, 
oxidized lipids are essential signals in cell death. Three PLox have been reported actively 
participated in the cell death process: (1) oxidized CL (CLox) and oxidized phosphatidylserine 
(PSox) in apoptosis, and (2) oxidized PE (PEox) in ferroptosis.   
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1.4.1 CLox and PSox in apoptosis 
1.4.1.1 CL 
CL is a dimeric anionic PL which contains one glycerol backbone, two phosphate groups and 
four fatty acyl chains, which can be conceptualized as two phosphatidic acids connected by a 
glycerol molecule. It is almost exclusively found in the mitochondrial inner membrane. This 
results its asymmetrical abundance in mitochondria. CL is less abundant compared to other PL 
classes in mitochondria (around 2-3 mol %) but highly abundant in the mitochondrial inner 
membrane (up to 20 mol %). The abundance of CL among tissue varies. It is the most abundant 
in the heart (10% in bovine heart tissue) and the skeletal muscle but present ubiquitously in all 
mammalian tissues [40]. The diversity of CL is tissue-dependent: in the mammalian heart, 
muscles, and liver the most abundant CL species is symmetric tetralinoleoyl CL [41]. However, 
in the mammalian brain CLs are highly asymmetric, containing abundant PUFAs [42-44]. CL is 
also found in prokaryotes but the fatty acyls are markedly different. CLs in prokaryotes contain 
shorter, saturated, monounsaturated, and odd-number fatty acids but in eukaryotes they contain 
longer-chain polyunsaturated residues [45]. It has been demonstrated that CL participates in 
various cellular functions including bioenergetics [46], mitochondrial dynamics [47], cell cycle 
progression [48], cellular aging [49], mitophagy [50, 51], lipid mediator generation [44], and 
apoptosis [52, 53].       
1.4.1.2 CL metabolism and disease 
Two routes of CL metabolism have been identified in mitochondria: biosynthesis and 
remodeling. In the biosynthesis route, phosphatidic acid (PA) is catalyzed by the CDP-
diacylglycerol (CDP-DAG) synthase activity of TAM41, forming CDP-DAG [54, 55]. The next 
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few enzymatic steps generate two intermediates phosphatidylglycerophosphates and 
phosphatidylglycerol (PG), and in a final step CL is formed by CL synthase (Crd) [56]. The CL 
formed in the biosynthesis route is termed “immature CL” as it contains mostly saturated fatty 
acyl chains. The immature CL undergoes remodeling to form “mature CL”, which is more 
unsaturated [56]. Remodeling of CL in yeast is catalyzed by two key enzymes: CL-specific 
deacylase 1 (Cld1) and tafazzin (Taz1). To be specific, Cld1 deacylates CL with a preference for 
palmitic acid (16:0) and stearic acid (18:0) [57] to form monolyso-CL (MLCL), and Taz1 
functions as a transacylase to reacylate unsaturated fatty acids to MLCL forming mature CL 
[58]. Notably, it is suggested that tafazzin alone is competent for CL remodeling, and other 
enzymes are found to contribute to the CL remodeling such as Acyl-CoA:lysocardiolipin 
acyltransferase-1 (ALCAT1) and MLCL acyltransferase-1 (MLCAT1) [59].  
Cld1 was first identified in 2009 and its phospholipase activity is very specific to CL 
[60]. This enzyme has no homolog in higher eukaryotes but its function, to remove acyl chains 
from CL, is similar to mammalian calcium-independent phospholipase A2γ [61]. Cld1 is 
associated with the inner leaflet of the mitochondrial inner membrane and responsible for the 
entry step of CL remodeling [62]. The mutant yeast lacking cld1 was found to be normal with 
respect to growth, oxidative phosphorylation, and mitochondrial morphology [63].  
The mutation of the gene that encodes tafazzin causes Barth syndrome (BTHS), an X-
linked recessive disorder that is associated with cardiomyopathy, skeletal myopathy, 
neutropenia, and organic aciduria [64, 65]. The frequency of BTHS is estimated to be 1 in 
300,000 to 400,000 [66]. As a loss in the final step of the CL remodeling pathway, BTHS 
patients accumulate MLCL and are devoid of tetralinoleoyl CL [67, 68]. The ratio of MLCL to 
CL is suggested to be a diagnostic marker for BTHS [69]. Notably, the deletion of cld1 in yeast 
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could rescue the defection of the growth, lifespan, and respiration in the taz1 mutant, suggesting 
that the deleterious effect caused by the loss of taz1 is due to the increase in the ratio of MLCL to 
CL and not the decrease in CL unsaturation [70].  
1.4.1.3 CLox elicits apoptosis 
CL oxidation is a critical event in early apoptosis, and cyt C is responsible for this reaction. Cyt 
C has been known to be an electron carrier between mitochondrial Complex III and IV. It also 
acts as a superoxide scavenger. In apoptotic events, cyt C is an essential initiator of caspase 
cascades by binding to apoptosis protease-activating factor, Apaf-1, and facilitates the the 
formation of apoptosomes. Previous studies have shown that the peroxidase activity of cyt C is 
required for early apoptotic events [53]. Cyt C is capable of directly oxidizing anionic 
phospholipids, including CL and PS [71, 72]. At the onset of apoptosis, the externalization of 
CLs to the outer leaflet of the inner mitochondrial membrane allows the interactions with the 
intramembranous cyt C. Cyt C changes its conformation and switches its mode of electron 
transfer to peroxidase activity by interacting with CLs. In the presence of H2O2, cyt C acquires 
the ability to oxidize CLs with the formation of hydroperoxy- and hydroxy-CLs [72]. Linoleoyl 
CLs are preferentially oxidized by cyt c in vitro and in vivo [73-76]. Next, the decreased affinity 
of cyt C to CLox results in the release of cyt C into the cytoplasm through the pores in the 
mitochondrial outer membrane. It has been suggested that the interaction of CLox and Bcl-2 
proteins increases the mitochondrial outer membrane permeabilization and facilitates the release 
of pro-apoptotic factors [71]. 
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1.4.1.4 PSox promotes apoptotic cell clearance 
In normal cells, PS mainly resides in the inner leaflet of plasma membrane [77]. In apoptotic 
cells PS is externalized to the cell surface and serves as an efferocytotic signal for the clearance 
of apoptotic cells by macrophages [78, 79]. In fact, PS oxidation is not required for phagocytosis. 
However, clearance of apoptotic cells by phagocytosis becomes more effective when PSox is 
externalized on the cell surface [80]. During apoptosis, cyt C is responsible for the oxidation of 
not only CL but for PS as well [81]. The release of cyt C from mitochondria is critical for the PS 
oxidation and its subsequent appearance on the cell surface during apoptosis [82]. 
1.4.2 PEox in ferroptosis 
Ferroptosis is a newly-documented cell death program initially described as being iron-
dependent and lipid ROS-driven. It is morphologically, biochemically, and genetically distinct 
from other forms of cell death [83]. The ferroptotic inducer erastin inhibits system Xc- and 
abrogates cystine import and inhibits glutathione biosynthesis [83, 84]. Another ferroptotic 
inducer RSL3 is a direct inhibitor of glutathione peroxidase 4 (GPX4), the only enzyme that has 
been known so far to reduce hydroperoxy-PLs utilizing glutathione as a cofactor [84]. Selenium 
is required for GPX4 because it is used for the regeneration of a functional GPX4 after reactions 
with lipid hydroperoxides [85]. Vitamin E homologues (tocopherols and tocotrienols) prevent 
ferroptosis by binding to the catalytic sites of 15LOX [86]. Another study showed that, once 
bound, the endogenous metabolite of vitamin E, α-tocopherol hydroquinone, reduces the non-
heme active ferric iron to ferrous ion [87]. ACSL4 and LPCAT3 are positive regulators of 
ferroptosis. The former catalyzes the formation of polyunsaturated fatty acyl-CoA (with the 
preference for AA), and the latter catalyzes the formation of PE/PC from lyso-PE/PC (with the 
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preference of polyunsaturated fatty acyl-CoA) [88, 89]. In our previous study, hydroperoxy 
arachidonoyl and adrenoyl PE were identified as unique ferroptotic signals by quantitative redox 
lipidomics, reverse genetics and bioinformatics and systems biology [90]. Recently, PE-binding 
protein 1 (PEBP1) has been shown to change the substrate specificity of 15LOX from fatty acids 
to PLs [91]. Ferroptosis inhibitors, ferrostatin-1s and liproxstatin protect the liver, brain, kidney, 
and heart from ischemic injury in mouse models [92]. The protective role of these inhibitors is 
also shown in Parkinson’s disease [93], Alzheimer’s disease [94], traumatic [95] and 
hemorrhagic brain injury [96], ischemia-reperfusion kidney injury [97], acute renal failure [98], 
acetaminophen-induced primary hepatocyte cell death [99], and hemochromatosis [100]. Several 
other metabolic and signaling pathways have been shown to impact ferroptosis including PI3K 
[101], Nrf2 [102], p53[103-106], mevalonate pathways [107] and BRCA1-associated protein 
1[108].  
1.5 SACCHAROMYCES CEREVISIAE 
1.5.1 Lipidome 
The lipidome of the yeast Saccharomyces cerevisiae has been reported in several studies [109, 
110]. The most prominent characteristics of the S. cerevisiae lipidome is the lack of PUFA due to 
the presence of only one ∆9-desaturase encoded by ole1 [111]. Therefore, the yeast generates 
minimal lipid peroxidation [112].  However, in other strains of yeast such as Saccharomyces 
bayanus, Kluyveromyces thermotolerans, Pichia angusta, and Yarrowia lipolytica, PUFA-
containing glycerophospholipids are detected [113], which makes lipid peroxidation possible.  
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1.5.2 PUFA in yeast cell death 
The uptake of PUFA from the environment enriches the yeast lipidome with PUFA. PUFA can 
be toxic to the yeast under certain circumstances. One study showed that PUFA, including OA, 
LA and linolenic acid, are not toxic to wild-type yeast but rather induce mitochondrial necrosis 
in yeast with triacylglycerol biosynthesis defects [114]. Another study showed that LA induced 
cell density-dependent apoptosis and also increased the MDA [115]. The effect of PUFA 
supplementation on the yeast survival is also exposure-dependent. PUFA enrichment protects the 
yeast from lipophilic organometal toxicity [116] and increases the yeast’s ability to tolerate 
alkaline pH [117], but sensitizes the yeast to copper and cadmium toxicity [118, 119].  
The expression of exogenous desaturases enriches yeast with PUFA species [120-124]. 
Heterogeneous expression of plant ∆12-desaturase in yeast used in this thesis had no adverse 
effects on the yeast but it sensitized the yeast to oxidative stress, which results in cell death 
[125]. However, another study which expressed an exogenous fungi desaturase in yeast with a 
different genetic background results in a PUFA-producing strain with low viability [126].  
1.6 PSEUDOMONAS AERUGINOSA 
1.6.1 Epidemiology 
The Gram-negative bacterium P. aeruginosa is an opportunistic pathogen that is normally found 
in the environment, e.g. soil, water, and other moist locations. French pharmacist Carle Gessard 
first isolated it in 1882 from bluish-green pus [127]. The colonization of P. aeruginosa in healthy 
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adults is not common, and its prevalence of colonization is about 0-2% for the skin,  0-3% for the 
nasal mucosa, 0-6.6% for the throat, and 2.6-24% for the fecal samples [128]. To date, P. 
aeruginosa is one of the important pathogens that causes community- and nosocomial-acquired 
infections [129]. P. aeruginosa is the sixth most common opportunistic hospital pathogen 
reported by the National Health Care Safety Network (approximately 7.3%) [130]. It is the 
second most common pathogen isolated from patients with hospital-acquired pneumonia, 
healthcare-associated pneumonia, and ventilator-associated pneumonia (VAP, approximately 
16.5%) [131]. P. aeruginosa causes the highest mortality in VAP, up to 30% [132]. It is also the 
most common multidrug-resistant Gram-negative pathogen leading to VAP [133].  
1.6.2 Cystic fibrosis 
Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by the mutation of the 
gene encoding the CF transmembrane conductance regulator (CFTR) protein. The dysfunction of 
this protein interferes with the ion balance in airways and leads to an accumulation of mucus that 
hampers the mucociliary clearance [134]. Other factors that shape the pathological courses of CF 
include the abnormal structure of microbiota changes, the acidic environment, and airway 
inflammation in CF patients [135]. P. aeruginosa is the most common pathogen found in adult 
CF to date (over 70%) and the most important contributor to CF morbidity and mortality [136, 
137]. 
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1.6.3 Lipidome and lipid signaling in P. aeruginosa and other bacteria 
Gram-negative bacteria contain two membranes, the inner membrane and the outer membrane, 
with a solvent-filled periplasm between the two membranes. The outer membrane contains 
mostly glycolipids and lipopolysaccharides while the inner membrane contains 
glycerophospholipids. Like other Gram-negative bacteria, the major glycerophospholipid classes 
in P. aeruginosa are PE, PG, and CL [138, 139]. Most prokaryotes do not synthesize PUFA 
except for some marine bacteria such as Shewanella species [140, 141].  
PUFA can be imported from the environment and incorporated into 
glycerophospholipids. The effect of unsaturated fatty acids on bacteria can be beneficial or 
detrimental. It has been reported that PUFA supplementation to P. aeruginosa and the 
pathogenic Vibrio species affects the bacterial growth, membrane permeability, biofilm 
formation, and the resistance of antimicrobial peptides [142, 143]. Unsaturated fatty acid 
supplementation promotes motility in Proteus mirabilis and virulent gene expression in 
Staphylococcus aureus, Listeria monocytogenes, and P. aeruginosa [144-147]. However, some 
other reports have shown that PUFAs inhibit bacterial growth in P. aeruginosa, Helicobacter 
pylori, and Neisseria gonorrhoeae [148-150].  
Lipid is an essential factor contributing to bacterial growth, infection, and antimicrobial 
resistance. For example, phosphatidylcholine (PC) is usually absent in most prokaryotes but is 
present in the Gram-negative bacteria Brucella abortus. PC is an essential nutrient for this 
particular bacterium grown in minimal medium and essential to its virulence [151]. CL synthesis 
and outer membrane localization are essential to the virulence of Shigella flexneri [152] and 
Salmonella Typhimurium [153]. PS and phosphatidylinositol, which are present in mucus or on 
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the cell surface, facilitate P. aeruginosa binding and contribute to its initial colonization [154]. 
PL aminoacylation is used by bacteria to induce antimicrobial resistance [155, 156].  
Some studies have shown P. aeruginosa can trigger lipid peroxidation. For instance, 
nosocomial P. aeruginosa isolates can directly induce the production of MDA in PUFA-infused 
red blood cells [157]. Another study reported MDA increases in the P. aeruginosa-infected 
septic rat and the serum of P. aeruginosa-infected patients [158]. An earlier finding also reported 
that P. aeruginosa metabolizes arachidonic acid, however, the products and the enzyme 
responsible were not identified [159]. Fewer studies have been conducted on the role of lipid 
peroxidation in P. aeruginosa. The lipoxin synthase activity of pLoxA suggests that P. 
aeruginosa can downregulate host inflammatory responses via lipid peroxidation [21]. Another 
recent study showed that P. aeruginosa secretes epoxide hydrolase cystic fibrosis transmembrane 
conductance regulator inhibitory factor (Cif) to promote airway inflammation by interfering 
proresolving functions of lipoxins [160]. Notably, a recent study has showed that the organic 
hydroperoxide resistance enzymes, which are Cys-based, lipoyl-dependent peroxidases, are 
involved in the P. aeruginosa response to fatty acid hydroperoxides, implying a potential 
mechanism to combat lipid peroxidation [161].   
1.7 HYPOTHESIS AND RATIONALE 
PUFAs are the essential substrates for lipid peroxidation, whereby the oxidized lipid products are 
utilized as signaling molecules in mammalian cells. However, PUFAs are not synthesized 
endogenously in many organisms, including most of the prokaryotes and the eukaryotic yeast S. 
cerevisiae. Instead, these organisms obtain PUFAs from the environment, and interestingly, they 
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express enzymes that regulate oxidized lipids. These observations suggest that lipid peroxidation 
possesses significant functions in these organisms. However, the exact functions of the oxidized 
lipids and how the associated enzymes regulate them in these organisms are still not fully 
understood.  
In yeast, CL that is synthesized de novo undergoes remodeling [56]. Previous studies in 
yeast have shown that un-remodeled and remodeled CLs are functionally indistinguishable [63], 
and the deletion of cld1 can rescue the defects caused by the loss of the taz1 [70]. Therefore, it 
raises the question of why cells remodel CL. Notably, the expression of cld1 is upregulated in the 
stationary phase, which is in an active respiratory condition [70]. The expression of cld1 is also 
regulated by the respiratory transcription factors Hap2 and Mig1 [70]. Based on these studies we 
hypothesized that one possible function of CL remodeling is to remove CLox products, which 
are formed during respiration and have been shown to be required for the early onset of apoptosis 
in mammalian cells. It has been known that S. cerevisiae expressing H. brasiliensis Δ12-
desaturase synthesizes PUFAs and exhibits sensitivity to oxidants [125]. However, the effects of 
Δ12-desaturase expression on CL biosynthesis, remodeling, and peroxidation has not been 
explored quantitatively.  
    P. aeruginosa, a prokaryote which does not synthesize oxidizable PUFA-lipids, 
expresses pLoxA [20]. Previous reports have shown that PE is a preferred phospholipid substrate 
for pLoxA [21, 34]. Structurally, pLoxA possesses a spacious catalytic lobby for the 
accommodation of PE [21]. In addition, an endogenous non-PUFA-PE has also been co-
crystalized with pLoxA [162]. Indeed, P. aeruginosa utilizes host-derived PUFAs as substrates 
to form PUFAox, which potentially modulate inflammation and host immune responses [21, 
160]. However, the role of oxidized PE catalyzed by pLoxA in pathogen-host interactions 
 17 
remains unclear. Recently, 15-hydroperoxy-AA-PE generated by 15LOXes in mammalian cells 
have been shown to be signals for ferroptotic cell death. Thus, based on these recent discoveries, 
we hypothesized that P. aeruginosa can oxidize AA-PE in host cells via pLoxA and induce 
ferroptosis by hijacking the mammalian PUFA-PE and death program.         
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1.8  SPECIFIC AIMS 
The overall goal of this project is to investigate the roles of lipid peroxidation for signaling and 
its regulatory enzymes in organisms lacking PUFA synthesis. 
The specific aims of the project are: 
1) To characterize phospholipids and oxidized phospholipids in Δ12-desaturase-
expressing cld1Δ and wild-type yeast by mass spectrometry. 
2) To investigate the role of CL remodeling as a potential mechanism for the removal of 
CLox species. 
3) To test the hypothesis that P. aeruginosa utilizes pLoxA to induce ferroptosis in host 
cells thereby generating pro-ferroptotic lipid signals.   
4) To study the clinical significance of pLoxA in P. aeruginosa. 
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2.1.4 ABSTRACT 
Cardiolipin (CL) is a unique phospholipid localized almost exclusively within the mitochondrial 
membranes where it is synthesized. Newly synthesized CL undergoes acyl remodeling to 
produce CL species enriched with unsaturated acyl groups. Cld1 is the only identified CL 
specific phospholipase in yeast and is required to initiate the CL remodeling pathway. In higher 
eukaryotes, peroxidation of CL, yielding CLOX, has been implicated in the cellular signaling 
events that initiate apoptosis. CLOX can undergo enzymatic hydrolysis, resulting in the release of 
lipid mediators with signaling properties. Our previous findings suggested that CLD1 expression 
is upregulated in response to oxidative stress, and that one of the physiological roles of CL 
remodeling is to remove peroxidized CL. To exploit the powerful yeast model to study functions 
of CLD1 in CL peroxidation, we expressed the H. brasiliensis Δ12-desaturase gene in yeast, 
which then synthesized PUFAs that are incorporated into CL species. Using LC-MS based redox 
phospholipidomics, we identified and quantified the molecular species of CL and other 
phospholipids in cld1Δ vs. WT cells. Loss of CLD1 led to a dramatic decrease in chronological 
lifespan, mitochondrial membrane potential, and respiratory capacity; and increased levels of 
mono-hydroperoxy-CLs, particularly among the highly unsaturated CL species, including 
tetralinoleoyl-CL. In addition, purified Cld1 exhibited a higher affinity for CLox, and treatment 
of cells with H2O2 increased CLD1 expression in the logarithmic growth phase. These data 
suggest that CLD1 expression is required to mitigate oxidative stress. The findings from this 
study contribute to our overall understanding of CL remodeling and its role in mitigating 
oxidative stress. 
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2.1.5 INTRODUCTION 
The dimeric mitochondrial phospholipid cardiolipin (CL) is most abundant in the mammalian 
heart, where it was first discovered [163]; however, it is present in nearly all mammalian tissues 
and throughout the eukaryotic kingdom [164]. The cellular and subcellular functions of CL have 
been studied for decades using the powerful yeast genetic model, Saccharomyces cerevisiae 
[165]. Yeast genes encoding the CL biosynthetic enzymes (Fig. 1) have been identified, and 
well-characterized mutants are available for each step of the pathway, enabling in vivo studies of 
CL function that are not easily carried out in mammalian cells [166].  The yeast model has, thus, 
been pivotal in demonstrating the critical role of CL in mitochondrial bioenergetics [167-171], 
mitochondrial protein import [168, 172], mitochondrial dynamics [173, 174], cell cycle 
progression [48], cellular aging [49], and mitophagy [51] among other essential functions.  
CL that is synthesized de novo undergoes remodeling, in which it is deacylated to mono-
lyso-CL (MLCL), which is reacylated by the transacylase, tafazzin, thus forming CL species that 
are more unsaturated [60, 64]. Polyunsaturated tetralinoleoyl-CL (TLCL) is the major CL species 
detected in human and other mammalian heart, skeletal muscle and liver cells [64]. Despite the 
obvious energetic expenditures required for the biosynthesis of a unique homo-acylated TLCL, 
the physiological significance of TLCL remains unclear. It is absent from cells of patients with 
Barth syndrome (BTHS), an X-linked recessive disorder associated with variable 
cardiomyopathy, skeletal myopathy, neutropenia, and organic aciduria [64, 65]. BTHS is caused 
by mutations in the TAZ gene that codes for tafazzin [175]. Accordingly, BTHS patient cells 
accumulate MLCL and are devoid of TLCL, owing to a loss in the final step of the CL 
remodeling pathway [176]. In yeast, unremodeled and remodeled CL are thought to be 
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functionally indistinguishable [63], and deletion of the CL-specific phospholipase, Cld1, was 
found to rescue the defects caused by loss of the CL-transacylase, Taz1 [70]. This raises the 
question of why cells remodel CL, and how CL enriched with PUFAs are functionally distinct 
from those containing saturated or mono-unsaturated fatty acyl CL species. Recent studies 
indicate that peroxidation of CL is a powerful cell signaling event that can initiate apoptosis [73, 
75, 177-180]. Furthermore, the enzymatic hydrolysis of oxidized CL (CLOX), leading to the 
release of lipid mediators, may have diverse signaling properties [71, 98]. In the wild, yeast cells 
proliferate in diverse environments [181-184], from which PUFAs may be readily incorporated 
into CL. We previously reported that yeast cells supplemented with PUFAs linoleic acid  (C18:2) 
or arachidonic acid (C20:4) readily incorporate these fatty acids into CL [57]. Cipak and co-
workers demonstrated that S. cerevisiae cells expressing the H. brasiliensis Δ12-desaturase 
synthesize PUFAs and exhibit sensitivity to oxidative stress [125, 185]. However, the effect of 
Δ12-desaturase-expression on CL biosynthesis and remodeling or CL peroxidation has not been 
explored.   
In the current study, multiple species of CLOX, including mono-hydroperoxy-CL and di-
hydroperoxy-CL, were also detected in these cells. Further, oxidized species of two additional 
phospholipids abundant in mitochondria, phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE), were also detected. However, the oxidized form of 
phosphatidylserine (PS), which is lacking from mitochondria, was not detected. Thus, our 
findings suggest that yeast cells synthesizing PUFAs generate CLOX species within the 
mitochondria. We compared the CL profiles of Δ12-desaturase-expressing WT and cld1Δ cells. 
Δ12-Desaturase-expressing cld1Δ cells contain increased levels of mono-hydroperoxy-CLs, 
particularly among the highly unsaturated CL species, including TLCL. Furthermore, we 
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observed that CLD1 expression is upregulated in response to treatment with H2O2, and purified 
Cld1 protein exhibits higher activity towards hydroperoxy-TLCL than non-peroxidized TLCL. 
The presence of PUFA-containing CL and the production of CLOX were not associated with 
major growth defects under optimum conditions. Interestingly, loss of CLD1 in Δ12-desaturase-
expressing cells led to decreased chronological lifespan. These results suggest a novel role for 
Cld1 and CL remodeling in mitigating the effects of oxidative stress and CL peroxidation. 
Importantly, these findings provide a powerful genetic model that can be exploited to elucidate 
mechanisms underlying the generation and function of CL peroxidation. 
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2.1.6 MATERIALS AND METHODS 
2.1.6.1 Strains, Media, and Growth Conditions 
The S. cerevisiae strain used in this work is BY4741(MATa his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0). 
Plasmids pYES2-EV and pYES2-desa were kindly given by Dr. Ana Cipak Gasparovic (Rudjer 
Boskovic Institute, Zagreb, Croatia). Expression of the Δ12-desaturase is controlled by a Gal 
promoter and is induced by growth on galactose-containing medium. Complex medium 
contained yeast extract (1%), peptone (2%), and glucose (2%) (YPD). The solid medium 
contained agar (2%) in addition to the ingredients mentioned above. Synthetic complete (SC) 
ura- medium contained adenine (20.25 mg/liter), histidine (20 mg/liter), arginine (20 mg/liter), 
lysine (200 mg/liter), leucine (60 mg/liter), methionine (20 mg/liter), tryptophan (20 mg/liter), 
threonine (300 mg/liter), all the essential components of yeast nitrogen base without amino acids 
(Difco), 0.2% ammonium sulfate, and glucose/galactose (2%). Yeast strains were grown at 30°C. 
E. coli strain DH5-α was used for plasmid maintenance and amplification. Bacteria were grown
at 37°C in LB medium (0.5% yeast extract, 1% tryptone, 1% NaCl), supplemented with 
ampicillin (100 μg/mL) for selection purposes. For growth on plates, media were supplemented 
with 1.5 and 2% agar for E. coli and yeast, respectively. Growth in liquid cultures was monitored 
spectrophotometrically. For lipidomic analysis, cells were harvested and centrifuged at 4 °C 
(4,300 rpm, 5 min). The supernatant was discarded, and glass beads (0.3g) were added to the 
centrifuge tubes. Samples were vortexed (5 X 1 min intervals) and centrifuged again at 4 °C 
(4,300 rpm, 5 min). Supernatants were collected and frozen at -80 ℃ for lipidomic analysis.   
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2.1.6.2 Construction of Plasmids and Expression of Yeast His6-tagged Cld1 in S. cerevisiae 
To construct a His6-tagged CLD1 overexpression plasmid, a 1373-bp sequence containing the 
entire open reading frame without stop codon of CLD1 was amplified from yeast genomic DNA 
using an EcoRI-tagged forward primer CLD1_EcoRI_F3 (5’-
TGATTAATAAGAATTCAACACAATGTTCAAGTCAACTTTAAACTC-3’) and an XbaI-
tagged reverse primer CLD1_XbaI_R3 (5’-
ATTTTGAGATTCTAGATATTTTTTGCATTTCTTTCG-3’). The PCR products were purified 
using the Wizard SV gel and PCR clean-up system (Promega). The purified DNA fragments 
were ligated into the pYES2/CT cut with EcoRI and XbaI downstream of the GAL1 promoter. 
All the plasmids were amplified and extracted using standard protocols. The plasmids were 
transformed into yeast strains using a one-step transformation protocol. 
2.1.6.3 Purification of His6-tagged Cld1 
S. cerevisiae BY4741 was used to express the recombinant His6-tagged Cld1. Cells were grown 
at 30 °C in synthetic complete raffinose medium lacking uracil. Galactose (2%) was used to 
induce overexpression of the recombinant protein. Cell extracts were prepared by disrupting cells 
with glass beads (0.5 mm diameter), vortexing for 5 min intermittently. The disruption buffer 
contained 50 mM Tris-Cl (pH 8.0) and 300 mM NaCl. Protease inhibitor was added to the 
disruption buffer before breaking the cells. His6-tagged Cld1 was purified with Millipore® 
PureProteome nickel magnetic beads following manufacturer's instructions. Millipore® 
UFC503024 Amicon® Ultra-0.5 centrifugal filter concentrator (30 KD) was used to concentrate 
the protein and remove imidazole. Protein concentration was determined with BIO-RAD DC 
protein assay kit using bovine serum albumin as the standard.  
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2.1.6.4 Synthesis of CLs 
Commercially available CLs: 1,1’,2,2’-Tetramyristoyl-CL (TMCL, CL (14:0)4; 1,1’,2,2’-
Tetralinoleoyl-CL (TLCL, CL (18:2)4) and 1,2-Dioleoyl-sn-glycerol-3-phosphocholine (DOPC) 
were purchased from Avanti Polar Lipids Inc. (Alabaster, AL). 1,1’,2,2’-Tetrapalmitoyl-CL and 
(TPCL, CL (16:0)4) was synthetized and purified as previously described [35]. Hydroperoxy-
TLCL (TLCL-OOH, CL(18:2)3/18:2-OOH) was prepared in soybean lipoxygenase-catalyzed 
reaction (Cayman Chemical Company, Ann Arbor, MI) in 50 mM HEPES buffer, containing 100 
µM DTPA. To prevent the conversion of hydroperoxy-groups to secondary products during 
incubation, HEPES buffer was saturated with oxygen. After CL oxygenation, the crude product 
was purified by HPLC.  Internal MLCL (14:0)3 and reference standards MLCL (16:0)3 and 
MLCL (18:2)3 were prepared from the respective CLs by a PLA2 (porcine pancreatic, Sigma) 
driven reaction as described by Kim and Hoppel [186] with slight modifications. 
2.1.6.5 Chronological Lifespan 
Yeast chronological lifespan was determined by survival of non-dividing cells in a prolonged 
stationary culture  [187]. A protocol modified from the one previously described [188] was 
followed to assess the chronological lifespan. In brief, individual colonies were inoculated in 5 
mL of SC galactose medium and incubated overnight. The cultures were then diluted in 50 mL 
of SC galactose medium, and cells were allowed to grow until saturation during the first 24 
hours. At this time, cells stopped dividing and reached a maximum number. Viability was 
considered to be 100% at this time, and viable cells were measured by counting colonies that 
were formed following dilution and plating on YPD plates. Viable cells were measured every 
day in the same volume of cell culture and the percentage of cells that formed colonies on day 
one was determined.  
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2.1.6.6 Spotting Assay 
Cells were pre-cultured in SC galactose medium to the early stationary growth phase at 30 °C 
and washed with sterile water. 2.5 μL aliquots of a series of 10-fold dilutions of 0.5 units of A550 
cells were spotted onto the indicated plates and incubated at 30 °C for 3 days. 
2.1.6.7 Real-Time Quantitative PCR (RT-qPCR) Analysis 
Cells were grown to the indicated growth phase and harvested at 4 °C. Total RNA was extracted 
and purified using the RNeasy Mini Plus kit (Qiagen, Valencia, CA). Complementary DNA 
(cDNA) was synthesized using the first strand cDNA synthesis kit (Roche Applied Science) 
according to the manufacturer’s manuals. RT-qPCRs were performed in a 20 μL volume using 
Brilliant III Ultra-Faster SYBR Green qPCR Master Mix (Agilent Technologies, Santa Clara, 
CA). Triplicates were included for each reaction. The primers for CLD1 and ACT1 RT-qPCR are 
described previously [70]. RNA levels were normalized to ACT1. Relative values of mRNA 
transcripts were shown as fold change relative to indicated controls.  
2.1.6.8 Synthesis of Mito-AAPH 
2-[(E)-(2-Amino-2-imino-1,1-dimethyl-ethyl)azo]-2-methyl-propanamidine hydrochloride 
(2; yield, 82%): In ice-cold methanol (100 mL), 2,2’-azobis-2-methyl-propanimidamide  
(AAPH; 2,2’-azobis-2-methyl-propanimidamide, 1; 1 g; 3.7 mmol) was neutralized with NaOH 
(0.3 g; 7.4 mmol). The solvent was rotor-evaporated (25 oC; 10 torr) and the crystals formed 
were suspended in chloroform (100 mL). Undissolved 1 and NaCl were filtered off. Rotor-
evaporation of the filtrate afforded 2 (0.6 g; 3 mmol), which was used immediately for the 
preparation of 5.  
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(4-Chloro-4-oxo-butyl)-triphenyl-phosphonium bromide (4; yield, 65%): 3-
carboxypropyl(triphenyl)phosphonium bromide (3, 1 g; 2.3 mmol) was dissolved in chloroform 
(50 mL) containing thionyl chloride (3 g; 25 mmol) and dimethylformamide (DMF; 0.05 g; 0.68 
mmol), and the reaction solution was refluxed for 4 hours. The volume of the solvent was 
reduced to ~ 5 mL (rotor-evaporation; 25 oC; 150 torr) and trituration with n-hexane afforded 4 
(0.68 g), which was dried under vacuum (40 oC; 10 torr) for 1 hour. 
[2-[(E)-[2-Imino-1,1-dimethyl-2-(4-
triphenylphosphaniumylbutanoylamino)ethyl]azo]-2-methyl-propanimidoyl]ammonium 
chlorobromide (5; yield 45%): Chloroform (50 mL) containing 2 (0.5 g; 2.5 mmol) and 4 (1.12 
g; 2.5 mmol) was incubated for 24 hours at 0 oC. Thereafter, the solvent was rotor-evaporated 
(20 oC; 10 torr) and the dry residue was redissolved in minimal volume of ethanol. Trituration of 
the solution with diethyl ether afforded 5 (0.69 g), which was filtered and dried under vacuum 
(20 oC; 1 torr) for 30 min. ESI MS calculated for the triphenylphosphonium cation of 5 
(C30H38N6OP+), 529.64; found, 529.80. 
2.1.6.9 Mito-AAPH Treatment 
Mito-AAPH was diluted with ethanol to make a 50 mM stock. For the spotting assay, 50 µM 
Mito-AAPH was directly spread on the plate before the experiment. For liquid culture, 50 µM 
Mito-AAPH was added at log phase (A550≈0.5). 
2.1.6.10 Determination of mitochondrial membrane potential (MMP) 
Cells were grown in SC Gal Ura- medium to log phase and incubated with 500 nM TMRM for 
30 min at 30°C. Cells were washed, resuspended in warm medium and divided in half. One 
group was treated with 6 µM FCCP and the other group was untreated. The TMRM fluorescence 
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intensity was determined in 30,000 cells from each group using a LSR II flow cytometer in the 
Wayne State University Microscopy, Imaging and Cytometry Resources Core. Median 
fluorescence intensity was calculated after correcting for background TMRM fluorescence 
(values obtained after treatment with FCCP) using FlowJo v10.2.  
2.1.6.11 Respiration measurements 
Oxygen consumption rate (ORC) of intact yeast cells was analyzed via the polarographic method 
in a closed 500 μL chamber equipped with a micro Clark-type oxygen electrode (Oxygraph Plus 
System, Hansatech Instruments) at 30°C. Yeast cells were grown in synthetic complete medium 
until log phase. Cells were mixed in fresh medium with a cell density normalized to a protein 
concentration of 0.5 mg/mL followed by the measurement of respiration. KCN (0.2 mM) was 
added at the end of the experiment to inhibit cytochrome c oxidase, to correct for cytochrome c 
oxidase-independent oxygen utilization. Oxygen consumption was recorded on a computer and 
analyzed with Oxygraph plus software. Oxygen consumption rate (ORC) is defined as consumed 
O2 (nmol)/min/total protein (mg). 
2.1.6.12 Statistical Analysis 
The results are presented as mean ± S.D. values from at least three experiments, and statistical 
analyses were performed by paired/unpaired Student's t-test. The statistical significance of 
differences was set at p< 0.05. 
2.1.6.13 LC/MS assessment of phospholipids 
Lipids were extracted from cells, and the LC/MS analysis of phospholipids was performed as 
previously described [57]. Briefly, phospholipids were analyzed in negative mode using a 
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Dionex UltimateTM 3000 RSLCnano system coupled online to a Q-Exactive hybrid quadrupole-
orbitrap mass spectrometer (ThermoFisher Scientific, San Jose, CA). Lipids were separated on a 
normal phase column (Silica Luna 3 µm, 100A, 150x2 mm, (Phenomenex, Torrance CA)) with 
flow rate 0.2 mL/min using gradient solvents containing 5 mM CH3COONH4 (A – n-hexane:2-
propanol: water, 43:57:1 (v/v/v) and B - n-hexane:2-propanol: water, 43:57:10 (v/v/v). MS lipid 
standards used in this study were from Avanti polar lipids (Alabaster, AL). Analysis of LC-MS 
data was performed using software package Compound DiscovererTM (ThermoFisher Scientific) 
with an in-house generated analysis workflow and peroxidized phospholipid database.  
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2.1.7 RESULTS 
2.1.7.1 Expression of the H. brasiliensis Δ12-desaturase alters the molecular speciation of 
CL in S. cerevisiae cells 
Yeast cells that are not supplemented with exogenous fatty acids produce only saturated and Δ9-
mono-unsaturated fatty acyl residues, and cannot synthesize PUFAs [57]. To construct a yeast 
model with PUFA-containing CL, we expressed the H. brasiliensis Δ12-desaturase gene in yeast 
[125] and established its effect on the phospholipidome of these cells. As described in Figure 1, 
yeast readily produce 16:0-CoA and 18:0-CoA, which can be converted to 16:1-CoA and 18:1-
CoA via endogenous Δ9-desaturase activity. These acyl-CoA species can be incorporated into 
phosphatidic acid (PA) and used in the de novo synthesis of CL via the CL synthase (Crd1) -
catalyzed reaction to form nascent CL, which contains predominately saturated fatty acyl chains 
[189-192]. Nascent CL is deacylated by the phospholipase, Cld1, to form monolysocardiolipin 
(MLCL) [60, 62]. The transacylase, Taz1, utilizes donor phospholipids, particularly PC and PE, 
to acylate MLCL to form CL, with the concomitant formation of lyso-PC (LPC) and lyso-PE 
(LPE) [58, 193].  Multiple cycles of deacylation-reacylation lead to the synthesis of mature CL 
containing mainly unsaturated acyl chains [58, 193]. As we showed previously, Cld1 has a 
greater affinity for C16- than for C18-containing acyl chains [57]. Accordingly, the predominant 
CL species detected in yeast contain C18 acyl chains. 
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Figure 1. CL biosynthesis and remodeling in S. cerevisiae.  
Yeast cells readily produce 16:0-CoA and 18:0-CoA, which can be converted to 16:1-CoA and 
18:1-CoA via endogenous Δ9-desaturase activity. 16:1-CoA and 18:1-CoA can be further 
converted to 16:2-CoA and 18:2-CoA by the expressed Δ12-desaturase. All available acyl-CoA 
species can be incorporated into phosphatidic acid (PA) and used in the de novo synthesis of CL 
via CL synthase (Crd1). Newly synthesized CL contains predominantly saturated fatty acyl 
chains. Nascent CL may undergo Cld1-catalyzed deacylation to form mono-lyso-CL (MLCL). 
The transacylase, Taz1, utilizes donor phospholipids, particularly phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE), to reacylate MLCL to CL, accompanied by the formation of the 
hydrolysis products of PC and PE, lyso-PC (LPC) and lyso-PE (LPE). PC and PE are also 
synthesized from PA. Multiple cycles of deacylation-reacylation generate CL that contains 
mainly unsaturated acyl chains. 
 
The expression of Δ12-desaturase results in the production of 16:2-CoA and 18:2-CoA, 
which are incorporated into CL through de novo synthesis or via CL remodeling. As shown in 
Figure 2A expression of the Δ12-desaturase caused dramatic changes in CL composition. Wild-
type (WT) yeast cells expressing empty vector (EV) have predominantly species containing 
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saturated or mono unsaturated fatty acyls such as CL64:3, CL66:4, CL68:4, CL70:4 and CL72:4, 
while WT cells expressing the Δ12-desaturase contained predominantly CL66:5, CL68:5, CL70:6 
and CL72:7. The appearance of PUFA-CL species are readily observed in differential LC-MS 
spectra obtained by subtracting the spectrum corresponding to EV-expressing WT cells from the 
spectrum of Δ12-desaturase-expressing WT cells (red spectrum). Similarly, the loss of saturated 
and mono-unsaturated CL is apparent when subtracting the spectrum of Δ12-desaturase-
expressing WT cells from EV-expressing WT cells (blue spectrum) (Figure 2B). The quantitative 
assessment of individual CL species indicates that Δ12-desaturase expression resulted in the 
production of multiple PUFA-containing CL species and a concomitant reduction in the 
abundance of CL species containing saturated or monounsaturated fatty acids (Figure 2C and 
2D).  
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Figure 2. CL species synthesized in empty vector (EV)- and Δ12-desaturase (desa)-
expressing WT cells.  
Typical mass spectra of CL obtained from wild-type (WT) yeast cells expressing the empty 
vector (EV) (upper panel) or desa (lower panel). Major CL molecular species are identified as: 
CL58:3 (m/z 1261.8241); CL60:3 (m/z 1289.8578); CL62:3 (m/z 1317.8895); CL64:3 (m/z 
1345.9180); CL66:4 (m/z 1371.9358); CL68:4 (m/z 1399.9666); CL70:4 (m/z 1427.9991); 
CL72:4 (m/z 1456.0305); CL60:4 (m/z 1287.8410); CL62:4 (m/z 1315.8712); CL64:4 (m/z 
1343.9119); CL66:5 (m/z 1369.9176); CL68:5 (m/z 1397.9476); CL70:6 (m/z 1423.9635); 
CL72:7 (m/z 1449.9794). (B) A differential mass spectra of CL species were obtained to 
highlight individual CL species that were increased [+(desa-EV)] or decreased [−(desa-EV)] by 
the expression of desa. (C) Heat map of CL quantified from WT yeast cells expressing EV or 
desa. (D) Quantitative assessment of individual CL molecular species in WT cells expressing the 
EV or desa. 
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2.1.7.2 Δ12-desaturase expression leads to accumulation of CLOX 
The accumulation of CLOX was readily observed in WT cells expressing Δ12-desaturase (Figure 
3A-C). Mono-hydroperoxy-CL and di-hydroperoxy-CL species were observed in these cells. As 
anticipated, oxidized CL species were not detected in EV-expressing WT cells. Oxidized MLCL 
species were not found, but oxidized PG, particularly PG 36:4+2[O], was readily detectable in 
the Δ12-desaturase-expressing-WT cells (Figure 6A). The accumulated CLOX could be 
synthesized from either pre-oxidized PG (containing peroxidized fatty acid residues) (Figure. 4 
and Figure. 5) or generated from oxidizable PUFA-CL species via direct peroxidation or via re-
acylation with the transfer of peroxidized PUFA residues. 
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Figure 3. Peroxidized CL (CLOX) in desa-expressing WT cells. 
(A) Heat map of CLOX. (B) Quantitative assessment of total CLOX. (C) Quantitative 
assessment of individual CLOX molecular species. 
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Figure 4. Quantitative assessment of individual (A) PG and (B) PC molecular species in 
WT and cld1Δ yeast cells expressing desa. 
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Figure 5. Phosphatidylglycerol (PG) in EV- and desa-expressing WT cells. 
(A) Typical mass spectra of PG obtained from WT yeast cells expressing EV (upper panel) or 
desa (lower panel). Major PG molecular species identified as: PG32:1 (m/z 719.4892); PG32:2 
(m/z 717.4738); PG34:1 (m/z 747.5205); PG34:2 (m/z 745.5052); PG34:3 (m/z 743.4894); 
PG36:1 (m/z 775.5520) and PG36:2 (m/z 773.5364). (B) Quantitative assessment of individual 
PG species. 
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Fragmentations of non-peroxidized PUFA-CL, including 16:2 and 18:2 fatty acids, were 
found in our analysis, but the structural information related to the location of dienes was not 
available. In yeast, exogenous plant Δ12-desaturase utilized 16:1-CoA and 18:1-CoA that were 
generated by endogenous Δ9-desaturase as substrates [125], indicating that the location of dienes 
are at position 9 and position 12 in the 18:2 and 16:2 aliphatic chain. In addition, the 
fragmentations of CL mono-hydroperoxides and di-hydroperoxides were examined to precisely 
identify CL peroxidation and locate the oxygen within the species. However, the fragmentations 
were not able to be detected due to insufficient levels of CL peroxidation products (the ratio of 
oxidized CL in the analysis was about 0.13 mol% of total phospholipids and 2.5 mol% of non-
oxidized CL). In fact, the position of oxygen in CL monohydroperoxides and di-hydroperoxides 
was already identified via mass spectrometry in previous studies when the CL peroxidation was 
performed in vitro. Previously, the position of oxygen was structurally identified in CL generated 
from TLCL incubated with cyt C and H2O2, in which hydroperoxidation at position 9 and 
position 13 was detected [76]. In addition, soybean lipoxygenase incubated with CL specifically 
generated 13-hydroperoxy-CL and very low amount of 9-hydroperoxy-CL [194]. Recently, Shu-
Ping Hui and coworkers identified the position of oxygen in CL mono-hydroperoxides generated 
from oxidation of commercial bovine heart CL and HepG2 lipid extracts treated with 
CuSO4/H2O2 , showing that the oxygen atom was located at position 13 of linoleoyl chain [195]. 
However, the location of oxygens of CL peroxidation occurring within cells is still unknown. 
Further investigation is needed. 
2.1.7.3 Detection of other oxidized phospholipids in Δ12-desaturase-expressing-WT cells 
The effects of Δ12-desaturase expression on PC (Figure 6B and Figure 7), PE (Figure 6C and 
Figure 8), and PS (Figure 6D and Figure 9) were determined. All phospholipids analyzed in 
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these cells contained C16:2 and/or C18:2 fatty acyl chains. Oxidized species of PC (PCOX) and 
PE (PEOX) were detected in Δ12-desaturase-expressing cells. Interestingly, however, oxidized PS 
(PSOX) species were not found. Given that PC and PE species are enriched within mitochondrial 
membranes while PS species contribute minimally to the mitochondrial phospholipidome [196, 
197], this finding suggests that phospholipid peroxidation observed in Δ12-desaturase-expressing 
cells likely occurs within the mitochondrial subcellular compartment. This conclusion is further 
supported by the comparative data on the absolute amounts of oxidized phospholipids and their 
relative content (mol %) normalized to either total amounts of all phospholipids or the amounts 
of individual phospholipid classes (Table 1). The results show that the total oxidized 
phospholipid species constituted ~1% of the total PLs whereby PCOX products were the most 
abundant. Notably, the content of CLOX constituted ~2.5% of the CL species, compared to the 
levels of PCOX and PEOX, which were ~1.1% and 0.9% as normalized to PC and PE, respectively.  
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Figure 6. Heat maps of (A) PG and PGOX, (B) PC and PCOX, (C) PE and PEOX, (D) PS in 
WT cells expressing empty vector (EV) or desaturase (desa). 
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Figure 7. PC and PCOX species produced in EV- and desa-expressing WT cells. 
Typical mass spectra of PC obtained from WT yeast cells expressing EV (upper panel) or desa 
(lower panel). Major PC molecular species are identified as: PC28:0 (m/z 736.5158); PC28:1 
(m/z 734.5011); PC30:1 (m/z 762.5310); PC32:1 (m/z 790.5608); PC32:2 (m/z 788.5470); 
PC32:3 (m/z 786.5308); PC32:4 (m/z 784.5155); PC34:1 (m/z 818.5919); PC34:2 (m/z 
816.5786); PC34:3 (m/z 814.5621); PC34:4 (m/z 812.5461); PC36:1 (m/z 846.6246); PC36:2 
(m/z 844.6095); PC36:3 (m/z 842.5933); PC36:4 (m/z 840.5771). (B) Quantitative assessment of 
individual PC species in EV- and desa-expressing WT cells. Quantitative assessment of (C) PC 
with one, two and three oxygen and (D) individual PCOX molecular species in EV- and desa-
expressing WT cells. 
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Figure 8. PE and PEOX species produced in EV- and desa-expressing WT cells 
Typical mass spectra of PE obtained from WT yeast cells expressing EV (upper panel) or desa 
(lower panel). Major PE molecular species are identified as: PE32:1 (m/z 688.4932); PE32:2 
(m/z 686.4783); PE32:3 (m/z 684.4621); PE34:1 (m/z 716.5285); PE34:2 (m/z 714.5096); 
PE34:3 (m/z 712.4933); PE34:4 (m/z 710.4775); PE36:2 (m/z 742.5412); PE36:3 (m/z 
740.5251); PE36:4 (m/z 738.5092). (B) Quantitative assessment of individual PE species in EV- 
and desa-expressing WT cells. Quantitative assessment of (C) PE with one, two and three 
oxygen and (D) individual PEOX molecular species in EV- and desa-expressing WT cells. 
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Figure 9. PS species synthesized in EV- and desa-expressing WT cells. 
(A) Typical mass spectra of PS obtained from WT yeast cells expressing EV (upper panel) or 
desa (lower panel). Major PS molecular species are identified as: PS32:1 (m/z 732.4844); PS32:2 
(m/z 730.4685); PS32:3 (m/z 728.4528); PS34:1 (m/z 760.5148); PS34:2 (m/z 758.5000); 
PS34:3 (m/z 756.4842); PS36:1 (m/z 788.5476). (B) Quantitative assessment of individual PS 
species in EV- and desa-expressing WT cells. 
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Table 1. The absolute amounts of oxidized phospholipids and their relative content 
(mol%) normalized to either the amounts of total phospholipids or the amounts of 
individual phospholipid class in desaturase (desa)-expressing WT cells. 
  
PL class # of PLOX mol% to total PLs mol% to individual PL class 
CL 23 0.13 2.49 
PC 19 0.68 1.08 
PE 12 0.15 0.85 
PG 2 0.01 0.13 
PS 0 0 0 
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2.1.7.4 Δ12-desaturase expression results in an increased sensitivity to mitochondria-
targeted lipid peroxidation 
We next used a mitochondria-targeted azo-initiator of peroxyl radicals, mito-AAPH, to examine 
how CL peroxidation and growth are affected in Δ12-desaturase-expressing WT cells. We 
determined that Δ12-desaturase-expressing WT cells exhibit increased sensitivity to mito-AAPH 
(Figure 10A). As mito-AAPH partitions into mitochondria, it spontaneously decomposes at a 
constant rate to generate carbon-centered radicals, which, in aerobic conditions, are converted 
into peroxyl radicals that stimulate lipid peroxidation [198]. Exposure to mito-AAPH resulted in 
increased generation of specific mono-hydroperoxy-CL species, including CL62:6+2[O], CL 
64:8+2[O], CL66:7+2[O], CL66:8+2[O], CL68:8+2[O], and CL72:8+2[O] (Figure 10B). 
PC36:4+2[O] (Figure 10C), PE32:4+2[O], PE34:4+2[O] (Figure 10D), and PG36:4+2[O] 
(Figure 10E) were also increased. CL66:7+2[O] and PE34:3+2[O] were found only in 
desaturase-expressing WT cells exposed to mito-AAPH. Oxidized MLCL and PS were not found 
in desaturase-expressing WT cells exposed to mito-AAPH. These results suggest that the 
increased mitochondrial lipid peroxidation contributes to the overall growth defects observed in 
the Δ12-desaturase-expressing WT cells.  
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Figure 10. Effect of mito-AAPH on EV- and desa-expressing WT cells. 
(A) Serial 10-fold dilutions of cells were spotted on SC medium containing 2% galactose as 
carbon source. Mito-AAPH was spread on the plates immediately before spotting. Plates were 
incubated at 30°C for 3 days. (B) Heat map and quantitative assessment of individual CLOX 
molecular species in WT cells expressing Δ12-desaturase (desa) treated with or without mito-
AAPH. (C) Heat map and quantitative assessment of individual PCOX molecular species in WT 
cells expressing desa treated with or without mito-AAPH. (D) Heat map and quantitative 
assessment of individual PEOX molecular species in WT cells expressing desa treated with or 
without mito-AAPH. (E) Heat map and quantitative assessment of individual PGOX molecular 
species in WT cells expressing desa treated with or without mito-AAPH. 
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2.1.7.5 cld1Δ cells that express Δ12-desaturase exhibit decreased levels of PUFA-CLs 
including TLCL but increased levels of specific peroxidized CL species 
We have previously shown that expression of CLD1 is highest when cells are actively respiring 
[70]. These conditions lead to increased generation of ROS and a pro-oxidant environment 
conducive to enhanced PUFA lipid peroxidation. Increased CLD1 in these conditions suggests 
the possibility that Cld1 deacylates peroxidized CL, in which case the loss of CLD1 would lead 
to increased content of peroxidized CL. To investigate the role of Cld1 in deacylating 
peroxidized CL, we expressed the Δ12-desaturase in cld1Δ cells.  
In cld1Δ +desa, (Figure 11A), the LC-MS spectrum contained the signals from CL 
species formed through the biosynthesis. By subtracting this spectrum from the spectrum 
corresponding to the WT cells expressing Δ12-desaturase we obtained the differential LC-MS 
spectrum (Figure 11B) where the increasing red signals correspond to the remodeling products 
whereas the decreasing blue signals are derived from the substrates of remodeling pathway. In 
other words, CL species containing saturated and monounsaturated acyl chains were susceptible 
to remodeling, and the remodeling process yielded CL species with polyunsaturated fatty acyls. 
Quantitatively, these data are summarized in the heat-map (Figure 11C and Figure 12). PUFA-
containing CL species were detected in the Δ12-desaturase-expressing cld1Δ cells, likely because 
some incorporation of PUFA into CL occurs via de novo CL biosynthesis. Peroxidized CL 
species were also detected in cld1∆ cells expressing Δ12-desaturase. Surprisingly, although Δ12-
desaturase-cld1Δ cells had decreased total levels of peroxidizable CL (Figure 11D), they 
contained significantly more CLOX species within PUFA-CL species (CL64:7, CL64:8, CL66:7, 
CL66:8, CL68:7, CL68:8, CL70:8, and CL72:8) (Figure 13A-B). Notably, mono-hydroperoxy-
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CLs were mainly found in cld1Δ (Figure 13A-B), whereas di-hydroperoxy-CLs were 
predominately generated in WT cells (Figure 13A). 
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Figure 11. CL profile analysis of desa-expressing WT and cld1Δ yeast cells. 
(A) Typical mass spectra of CL species obtained from WT cells expressing desaturase (desa) and 
cld1Δ cells expressing desa (cld1Δ+desa). (B) Differential mass spectral analysis of CL profiles 
highlights individual CL species that were increased (product of remodeling) or decreased 
(substrate for remodeling) by the deletion of CLD1. Major CL molecular species are identified 
as: CL60:3 (m/z 1289.8560); CL62:4 (m/z 1315.8712); CL64:4 (m/z 1371.9014); CL66:4 (m/z 
1371.9329); CL70:6 (m/z 1423.9635); CL72:7 (m/z 1449.9794); CL60:2 (1291.8715); CL62:2 
(m/z 1319.9023); CL66:3 (m/z 1373.9482); CL68:3 (m/z 1401.9790); CL72:6 (m/z 1451.9932). 
(C) Heat map of CL molecular species of WT or cld1Δ cells expressing desa. (D) Quantitative 
assessment of peroxidizable CLs in desa-expressing WT and cld1Δ yeast cells.
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Figure 12. Heat maps of CL molecular species in cld1Δ cells expressing empty vector 
(cld1Δ+EV) or desaturase (cld1Δ+desa). 
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Figure 13. CL and CLOX in desa-expressing WT and cld1Δ yeast cells. 
(A) Heat map of CLOX molecular species of WT or cld1Δ yeast cells expressing desa (B) 
Quantitative assessment of specific CL and mono-hydroperoxy-CL species (with 7 or 8 double 
bonds) including tetralinoleoyl-CL (TLCL) in desa-expressing WT and cld1Δ yeast cells. 
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2.1.7.6  Cld1 mitigates the effects of CL peroxidation 
As both non-oxidized as well as peroxidized PUFA-CL species may be hydrolyzed by Cld1, we 
performed in vitro experiments which showed that Cld1 exhibits greater affinity for the latter 
than for the former (Figure 14A-D). Incubation of DOPC/CL (16:0)4; DOPC/CL (18:2)4 and 
DOPC/CL (18:2)3/18:2-OOH liposomes with Cld1 isolated from S. cerevisiae resulted in the 
accumulation of two molecular species of MLCL respectively. The signals at m/z 1113.7 and 
1185.7 corresponded to 16:0/16:0/16:0 and 18:2/18:2/18:2 molecular species. Quantitatively, the 
larger signals were formed from TPCL and TLCL-OOH respectively and a much weaker signal 
(also at m/z 1185.7) from TLCL (Fig. 14B). These data indicate that CL (18:2)4 was a relatively 
“poor” substrate for Cld1, whereas both CL (16:0)4 and CL (18:2)3/18:2-OOH were readily 
hydrolyzed by the enzyme (Fig. 14B). We have previously shown that CLD1 expression is 
increased during respiratory growth and regulated by the HAP complex [70]. It is plausible that 
increased CLD1 expression during respiratory growth mitigates the effects of superoxide anions 
and their dismutation product H2O2 generated by respiratory complex III. This would likely 
contribute to the enhanced peroxidation of CL. Consistent with this possibility, WT cells treated 
in the log phase with H2O2 for 1 hr exhibited a 2-fold increase in CLD1 expression (Figure 14E). 
The chronological life span of cld1Δ was dramatically decreased by expression of Δ12-desaturase 
(Figure 15A), while the lifespan of wt cells expressing the Δ12-desaturase was not affected. 
Interestingly, while desaturase expression increased the mitochondrial membrane potential and 
respiratory capacity in wt cells, the mitochondrial membrane potential and respiratory capacity in 
cld1Δ cells were decreased (Figure 15B-C). Taken together, these findings support a role for 
Cld1 in mitigating the effects of CL peroxidation.  
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Figure 14. Cld1 exhibits greater affinity for oxidized than non-oxidized CL in vitro and its 
expression is increased by supplementation of H2O2.  
(A) A mixture of 10 μM CL that contains TLCL and oxidized TLCL (TLCLOX) in HEPES buffer 
pH 7.4 was incubated at 37 ℃ for 45 min with Cld1. Total TLCL was extracted by the Folch 
procedure, and TLCL, TLCLOX, and MLCL were quantified by LC-MS. Hydrolysis of CLOX was 
evident by an accumulation of MLCL and concomitant reduction of CLOX. n=3, *p = 0.020, and 
**p= 0.007, respectively. (B) Liposomes containing DOPC and CL (10 μM, 1:1) - DOPC/TPCL; 
DOPC/TLCL and DOPC/TLCL-OOH were prepared by sonication (Ultrasonic Homogenizer 
4710 series, Cole-Parmer Instrument Co., Chicago, IL) and treated with Cld1 (0.5 μg of protein) 
in 50 mM HEPES at pH 7.4, containing 100 μM DTPA for 20 min at 37 °C. After extraction, CL 
hydrolysis was detected by reduction of CL content and accumulation of MCL: ((16:0)4  
(16:0)3; (18:2)4  (18:2)3 and (18:2)3/(C18:2-OOH)  (18:2)3). n=3, *p = 0.030, and **p= 
0.027, respectively. (C) Isolated Cld1 was incubated with TLCL or with mixture of TLC + 
TLCLOX (ratios 1:1). (D) Isolated Cld1 was incubated with TLCL, TLCL containing one mono-
hydroperoxy-linoleic acid (LA) residue (TLCL+2[O]), or TLCL containing two mono-
hydroperoxy-LA residues (TLCL+4[O]). In the presence of CLOX (TLCL+2[O] or TLCL+4[O]) 
Cld1 generated significantly increased free mono-hydroperoxy-LA (m/z 311) than non-oxidized-
LA (m/z 279). (E) WT cells were grown to the mid-logarithmic phase and treated with 1 mM 
H2O2 for 1 hour. Analyses CLD1 expression in H2O2-treated cells and non-treated cells was 
determined using RT-qPCR. *p = 0.050 vs WT. 
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Figure 15. Analysis of chronological lifespan and mitochondrial functions of desa-
expressing yeast cells. 
(A) The chronological lifespan of WT and cld1Δ yeast cells expressing desa or EV. The data 
depicted are representative of three experiments. (B) Mitochondrial membrane potential is 
increased in WT+desa but reduced in cld1Δ+desa. Membrane potential of growing cells was 
determined by fluorescence quantification of the membrane potential dependent dye TMRM. (C) 
Mitochondrial respiratory capacity is decreased in cld1Δ +desa compared with cld1Δ+EV. Cells 
were grown in synthetic complete medium with galactose as carbon source. Respiration of intact 
cells was analyzed via the polarographic method. *p<0.05 versus control (n=3). 
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2.1.8 DISCUSSION 
This study demonstrates for the first time that Δ12-desaturase expression in yeast promotes the 
formation of PUFA-containing CL species that are readily peroxidized in vivo without any pro-
oxidant stimulation. To date, the study of processes governing CL peroxidation and the various 
cellular signaling functions of CLOX and CLOX-derived lipid mediators has not been possible 
using yeast model systems. We have confirmed that 16:2-CoA and 18:2-CoA produced by yeast 
expressing the Δ12-desaturase are incorporated into CL. This likely occurs, in part, during de 
novo synthesis of CL from PUFA-containing PG and CDP-diacylglycerol by CL synthase, with 
subsequent enrichment of CL with PUFA occurring during CL remodeling.  
This is the first study to identify a role for Cld1 in mitigating the effects of CL 
peroxidation. Previously, we determined that deletion of CLD1 rescues the respiratory growth 
defect of tafazzin deficient yeast cells, indicating that an increased MLCL/CL ratio, not a 
decrease in CL containing unsaturated fatty acyl chains, is detrimental to tafazzin deficient cells 
[70]. Similarly, a study by Baile and colleagues illustrated that unremodeled and remodeled CL 
are functionally indistinguishable in yeast [63]. An interesting question arises from these 
observations: why do yeast require CL remodeling if there is no adaptive advantage of 
accumulating CL dominated by unsaturated fatty acyl chains? A clue to answering this question 
comes from our current findings, which indicate that expression of CLD1 is increased in 
response to respiratory growth conditions, and this increase is mediated by the HAP and Mig1 
transcriptional factors. Baile and coworkers revealed that Cld1 protein level and function are 
decreased when cells are grown on glucose and increased when grown on the non-fermentable 
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carbon source, lactate [62]. They observed that CL remodeling is regulated by carbon source and 
mitochondrial membrane potential. Mitochondria are the major producer of cellular ROS, and 
CL-hydroperoxides are known to reduce oxidative metabolism by inactivating complex IV [199]. 
Similarly, respiratory chain defects have been shown to increase ROS production and decrease 
the membrane potential [200, 201]. These findings support a model in which decreased 
membrane potential resulting from the accumulation of CL-hydroperoxides serves as a signal to 
activate CL remodeling. This model is further supported by the notion that CL remodeling may 
function to remove peroxidized fatty acyl residues from CL, thereby mitigating the downstream 
consequences of mitochondrial CL-hydroperoxide accumulation, possibly including mitophagy 
or apoptosis. In mammalian cells, Liu et al. demonstrated that iPLA2γ, a gene product whose 
function is analogous to Cld1, as the major enzyme responsible for deacylation of oxidized 
aliphatic chains from CL [202]. Deletion of iPLA2γ results in the accumulation of peroxidized 
CL in mouse mitochondria when subjected to oxidative stress. However, it is unclear if this 
model applies to yeast cells because the loss of cld1 does not cause any detectable functional 
defects [63]. CL-hydroperoxides are not produced in either WT or cld1Δ cells unless PUFA is 
supplied in the growth medium or an exogenous-desaturase is expressed [57]. WT yeast cells 
readily incorporate PUFA into CL, which suggests that CL enriched with PUFA may influence 
cellular function in S. cerevisiae.  
In the current study, we used Δ12-desaturase-expressing cells to study the functions of 
Cld1 and CL remodeling in the presence of PUFA-containing CL and reveal that loss of Cld1 
causes an accumulation of CLOX species among the C18:2-containing-CL and decreased 
chronological lifespan. These results suggest that Cld1 is involved in removing C18:2-
hydroperoxide acyl moieties from CLOX species. This is supported by the demonstration that 
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purified Cld1 has a higher affinity for peroxidized (C18:2)4CL than non-peroxidized (C18:2)4CL. 
This may explain the previous observation that CLD1 expression is upregulated during the 
stationary phase and that CLD1 upregulation is respiration dependent [70]. Consistent with this 
model, H2O2 treatment, which leads to increased oxidative stress, upregulates CLD1 expression.  
In the current study, we found that Δ12-desaturase-expressing WT cells exhibit increased 
sensitivity to mito-AAPH, and treatment with mito-AAPH was associated with an increase in 
C18:2-containing-CLOX species. Increased sensitivity to lipid peroxidation was previously 
reported using this genetic yeast model [185]. However, our comprehensive lipidomics approach 
provides compelling evidence to implicate mitochondrial redox reactions and CL peroxidation in 
contributing to the growth defects observed in Δ12-desaturase-expressing WT cells. Excessive 
generation of CLOX in response to mitochondrial oxidative stress likely contributes to the small 
but significant growth defect observed under these conditions.  
The absence of oxidized PS supports a model of mitochondria-localized phospholipid 
peroxidation. PS species are confined almost exclusively to the cell membrane and secretory 
vesicles [203]. Although PS is imported into mitochondrial membranes, its intra-mitochondrial 
transport is linked to enzymatic conversion to PE by PS decarboxylase [204-206]. Thus, the 
relative abundance of PS within the mitochondrial membranes is minimal when compared to PG, 
PC and PE [203]. Peroxidation of CL, PG, PC, and PE but not PS suggests that phospholipid 
peroxidation observed in Δ12-desaturase-expressing cells likely occurs within the mitochondrial 
subcellular compartment. In yeast, beta-oxidation exclusively occurs in the peroxisome, but in 
mammalian cells, it occurs within both mitochondria and peroxisome. To be specific, short chain 
fatty acids (C6-C20) are degraded by mitochondrial beta-oxidation, but long chain fatty acid 
(>C20) are oxidized in the peroxisome. Hydrogen peroxide resulting from oxygen in the first 
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step of beta-oxidation is the major source of ROS in the peroxisome. Mitochondria, especially 
the electron transport chain, have long been considered the major source of ROS, including 
superoxide radicals, hydrogen peroxide, and hydroxyl radicals [207]. In mammalian cells, ROS 
are predominantly generated from Complex I and Complex III, while in Saccharomyces 
cerevisiae ROS are generated only by Complex III due to the lack of Complex I [208, 209]. 
Indeed, hydrogen peroxide can easily permeate through the membrane, and peroxisomal catalase 
deletion in Saccharomyces cerevisiae leads to a high level of intracellular hydrogen peroxide 
[210]. It is possible that ROS generated from peroxisomes contribute to mitochondrial CL 
peroxidation, and PC/PE peroxidation in yeast. However, the exact contribution of this “trans-
organellar” process is not well-understood. The yeast cells used during this study were in 
stationary phase, during which respiratory activity is relatively high. Respiration takes place in 
mitochondria, suggesting that the ROS-mediated oxidation of CL, PC, and PE is primarily of 
mitochondrial origin. 
While substantial evidence exists to link the accumulation of mitochondrial hydroperoxy-
CLs with cytotoxicity and apoptosis, the precise catalyst of CL peroxidation remains to be fully 
elucidated. CL peroxidase activity of cytochrome C (cyt C) has been identified as the primary 
enzymatic mechanism leading to the accumulation of CLOX in mammalian mitochondria [53, 
81]. Thus, it is tempting to speculate that cyt C is responsible for peroxidation of CL in yeast 
mitochondria. This is compatible with the indications of the less stringent barrier and easier 
activation of yeast vs. mammalian cyt C into a peroxidase [211, 212]. Importantly, cyt C does 
not exhibit appreciable peroxidase activity toward phospholipid species other than CL [213]. Our 
findings in the Δ12-desaturase-expressing WT cells indicate that yeast mitochondria readily 
accumulate oxidized species of PC and PE, which suggests that enzymatic peroxidation by cyt C 
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may not be the sole mechanism contributing to the formation of oxidized phospholipids in yeast 
mitochondria. In mammalian cells, 15-lipoxygenase (15LOX) enzymes are major catalysts of PE 
peroxidation that participate in ferroptotic cell death [214]. As 15LOX enzymes have not been 
identified in the yeast genome, the catalysts of phospholipid peroxidation in yeast cells remain to 
be identified.  
Mammalian cells effectively reduce hydroperoxy-phospholipids to hydroxy-
phospholipids via a glutathione peroxidase 4 (GPX4)-dependent enzymatic mechanism [214, 
215]. However, the yeast glutathione peroxidase enzymes appear to be incapable of reducing 
hydroperoxy-phospholipids. The predominant accumulation of hydroperoxy-CL, hydroperoxy-
PC, and hydroperoxy-PE species in the absence of corresponding hydroxy-phospholipids is 
indicative of relative inefficiency of this pathway in yeast. S. cerevisiae has three glutathione 
peroxidase enzymes encoded by GPX1, GPX2, and GPX3, all of which are believed to have 
hydroperoxy-phospholipid reducing glutathione-dependent peroxidase activity. While the loss of 
GPX1/2/3 confers sensitivity to supplementation with linolenate [216, 217], our findings in the 
Δ12-desaturase-expressing WT cells indicate that yeast glutathione peroxidase enzymes do not 
readily reduce endogenously produced hydroperoxy-phospholipids in vivo.  Given the recently 
established role of GPX4 in thwarting ferroptotic programmed death via reduction of 
hydroperoxy-phospholipid [84, 98, 214], it is interesting to speculate if this newly discovered 
cell death program can be realized in yeast cells [218].  
CL peroxidation provides a critical signal for the initiation of apoptosis [81, 219, 220], 
and therapeutic reduction of CL peroxidation is being explored to treat human diseases 
associated with apoptosis [221-223]. Hydrolysis of CLOX likely serves as a key mitochondrial 
source of oxidized fatty acid lipid signaling molecules [44]. The expression of exogenous 
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desaturase enzymes in yeast has variable effects on cellular function and viability depending on 
the yeast strain, and growth conditions used [125, 126, 185, 224]. Johansson and co-workers 
observed severe growth defects in cells expressing both Δ12 and Δ6-desaturase enzymes [126]. 
Cipak and co-workers report distinct effects of Δ12-desaturase expression depending on the yeast 
strain used [125, 185, 224]. The current study is the first to perform unbiased lipidomic analysis 
of yeast cells expressing an exogenous desaturase enzyme. Our findings indicate that CLOX is 
readily detected in Δ12-desaturase-expressing yeast under normal growth conditions, suggesting 
that CL peroxidation may occur in the absence of cytotoxic stressors. The Δ12-desaturase-
expressing yeast provides a powerful tool for the study of CL peroxidation and CLOX signaling. 
Future studies will explore potential inducers of CL peroxidation as well as functions of CLOX 
using this model system.   
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2.2 PSEUDOMONAS AERUGINOSA UTILIZES HOST POLYUNSATURATED 
PHOSPHATIDYLETHANOLAMINES TO TRIGGER THEFT-FERROPTOSIS IN 
BRONCHIAL EPITHELIUM. 
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2.2.4 ABSTRACT 
Ferroptosis is a death program executed via selective oxidation of arachidonic acid-
phosphatidylethanolamines (AA-PE) by 15-lipoxygenases. In mammalian cells and tissues, 
ferroptosis has been pathogenically associated with brain, kidney, liver injury/diseases. We 
discovered that a prokaryotic bacterium, Pseudomonas aeruginosa (P. aeruginosa), that does not 
contain AA-PE, can express lipoxygenase (pLoxA), oxidize host AA-PE to 15-hydroperoxy-AA-
PE (15-HOO-AA-PE) and trigger ferroptosis in human bronchial epithelial cells. Clinical P. 
aeruginosa isolates from patients with persistent lower respiratory tract infections induced 
ferroptosis dependently on the level and enzymatic activity of pLoxA. Redox phospholipidomics 
revealed elevated levels of oxidized AA-PE in airway tissues from patients with cystic fibrosis 
(CF) but not with emphysema or CF without P. aeruginosa.  We believe that the evolutionarily 
conserved mechanism of pLoxA-driven ferroptosis may represent a potential therapeutic target 
against P. aeruginosa-associated diseases such as CF and persistent lower respiratory tract 
infections. 
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2.2.5 INTRODUCTION 
Ferroptosis is a cell death program that is executed via activation of a selective enzymatic 
process of lipid peroxidation (LPO) catalyzed by 15-lipoxygenases (15LOX), dioxygenases for 
polyunsaturated fatty acids (PUFA), under conditions when hydroperoxy-phospholipids cannot 
be enzymatically inactivated by a specific seleno-peroxidase, glutathione peroxidase 4 (GPX4) 
[218, 225]. We recently identified the substrates and the products of this process as arachidonoyl 
(AA)-phosphatidylethanoamine(PE) and 15-hydroperoxy(HOO)-AA-PE, respectively (1, 3).  We 
further discovered that two isoforms of mammalian 15LOX – 15LOX1 and 15LOX2 – form a 
complex with a scaffold protein, PE-binding protein 1 (PEBP1), that switches the substrate 
specificity of 15LOX from free AA to AA-PE [33]. While 15LOXes are widely represented in 
many eukaryotic cells [18, 19, 226], they were also found in prokaryotes, particularly in several 
genera of bacteria [227, 228]. Surprisingly, 15LOX was also detected in Pseudomonas 
aeruginosa (PA1169, hereafter referred to as pLoxA), an organism that lacks oxidizable PUFA-
lipid substrates for 15LOX [20, 34]. Structural and computational studies established significant 
differences between the mammalian 15LOXes and pLoxA, including a more spacious catalytic 
“lobby” readily accommodating a bulky PE in the latter [21, 162]. Moreover, endogenous non-
PUFA-PE was found to co-crystallize with the protein in spite of the fact that it is a very poor 
substrate for the enzyme [162].     
In attempts to resolve this conundrum, we suggested that, as a bacterial pathogen, P. 
aeruginosa can oxygenate AA-PE in host cells and induce “theft-ferroptosis” by hijacking the 
mammalian PUFA-PE and death program. Here, we discovered that a biofilm producing mutant 
of P. aeruginosa is capable of inducing ferroptosis in human bronchial epithelial (HBE) cells via 
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enhanced expression of pLoxA and oxidation of host cell AA-PE to 15-HOO-AA-PE. Clinical P. 
aeruginosa isolates from persistent lower respiratory infection patients caused pLoxA-dependent 
ferroptosis of HBE cells. By employing global redox phospholipidomics, we further detected 
elevated levels of 15-HOO-AA-PE in airway tissues from patients with cystic fibrosis (CF) but 
not from patients with emphysema or CF without P. aeruginosa in airway cultures. Assuming 
that disruption of epithelial barrier and immune-regulatory functions are important for 
pathogenesis of P. aeruginosa-associated respiratory diseases we propose that pLoxA may 
represent a new therapeutic target. 
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2.2.6 MATERIALS AND METHODS 
2.2.6.1 Reagents.  
Minimal essential medium (MEM) (Thermo Fisher,11095-080), Fetal calf serum (Gibco,10437-
028), Lysogeny broth (LB) (Sigma, L3152), z-VAD-fmk (Millipore, 627610), necrostatin-1s 
(BioVision, 2263), bafilomycin-A1 (Sigma-Aldrich, B1793), RSL3 (Selleck chemicals, S8155), 
ferrostatin-1 (Sigma-Aldrich, SML0583), PD146176 (4079-26-9) and ML351 (847163-28-4) 
(Cayman Chemicals), 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine (SAPE) 
(Avanti Polar Lipids, 850804), bovine serum albumin (BSA) (Sigma),  Pierce 660 nm protein 
assay (Thermo Fisher Scientific, 22660), Pierce BCA protein assay kit (Thermo Fisher 
Scientific, 23225), MTT (Thermo Fisher, M6494), arabinose (Sigma, A3256), deoxycholic acid 
(Thermo Fisher, BP349),  anti-GPx4 (rabbit monoclonal, abcam, ab125066), anti-ACSL4 (F-4) 
(mouse monoclonal, sc-365230), anti-LPCAT3 (goat ployclonal, sc-161831) from Santa Cruz, 
anti-actin (mouse monoclonal, Sigma-Aldrich, A3854, clone AC-15), anti-Pseudomonas 
aeruginosa PA-I galactophilic lectin ployclonal antibody (rabbit ployclonal, Mybiosource, 
MBS1495605), secondary antibodies, rabbit anti-mouse (A9044), goat anti-rabbit (A0545)  and 
rabbit anti-goat (A5420) were from Sigma-Aldrich. 
2.2.6.2 Cell Culture.  
HBE cells (a human bronchial epithelial cell line originally established by Dr. Dieter Gruenert)  
were cultured in MEM (Thermo Fisher Scientific) supplemented with 10% fetal calf serum 
(Gibco), 50 Uml-1 penicillin-streptomycin (Thermo Fisher Scientific), plasmocin (InvivoGen) 
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and L-glutamine (Thermo Fisher Scientific).  HBE cells till passage 50 were used for 
experiments.  
2.2.6.3 Bacterial strains.  
P. aeruginosa wild-type (MPAO1), loxA::Tn (PA1169 transposon deletion mutant) (PW3111) 
and hyper-biofilm mutant (ΔwspF) strains were obtained from the P. aeruginosa transposon 
mutant library, The University of Washington (Seattle, WA) [229]. PAO1 isogenic strain, rugose 
small colony variant MJK8 and its loxA deleted strain MJK8∆PA1169 (herein referred to as 
MJK8∆loxA) were generated as previously described [230]. 
2.2.6.4 P. aeruginosa ICU respiratory isolates.  
Tobramycin-resistant P. aeruginosa respiratory isolates from intensive care units were identified 
at the clinical microbiology laboratory of University of Pittsburgh Medical Center (IRB# 
PRO12060302) and name as TRPA0022-TRPA1122. For confirmation, the isolates were re-
identified as P. aeruginosa using a commercial biochemical panel (API 20NE system, 
bioMerieux, Durham, NC). PA14 strain [231] is a reference clinical P. aeruginosa strain 
originally isolated from a burn patient and the fully sequenced genome of PA14 is publicly 
available. 
2.2.6.5 loxA::Tn Complementation.  
PW3111 (MPAO1 loxA::Tn) was complemented with an arabinose-inducible promoter at the 
chromosomal attTn7 site as previously described using pUC18-miniTn7T-Gm-GW [232]. From 
genomic MPAO1 DNA, PA119 was amplified using primers attB5-RBS-loxA-F and attB2-
loxAdown-R (Table 2), which included the entire loxA coding region and introduced a synthetic 
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ribosomal binding site. The loxA amplicon was gel purified and recombined into 
pDONR221P5P2 (Table 2) using BP Clonase II (Invitrogen). The resulting entry vector, 
pENTR221L5L2::RBS-PA1169, was transformed into E. coli DH5α and insertions were 
checked by PCR and Sanger sequencing (Eurofins) using primers M13F(-21) and M13R. We 
used Multisite Gateway Technology (Invitrogen) to recombine pENTR221L1L5r::araC-PBAD 
(the plasmid pENTR221L1L5r::araC-PBAD:was  a generous gift from Dr. Joe Harrison, 
Department of  Biological Sciences, University of Calgary, Calgary, Canada) and 
pENTR221L5L2::RBS-PA1169 with pUC18miniTn7T-Gm-GW, generating the 
complementation vector pUC18miniTn7T::PBAD-PA1169. The complementation vector was 
transformed into E. coli DH5α and plasmids from transformants were sequenced using primers 
pBAD-F and pUC18BackboneR01. To complement PW3111, we electroporated 
pUC18miniTn7T::PBAD-PA1169 and pTNS3 into PW3111. Transformants were selected on LB 
with 30 µg/mL gentamycin and colony PCR was performed using primers PTn7R and PglmSdown as 
previously described [232] to identify an insertion at the attTn7 site on the chromosome (Table 
2). All the E. coli strains, plasmids and primers used for complementation studies are given in 
Table 2.  
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Table 2. Bacterial strains, plasmids, and primers used for loxA complementation study. 
Strains Characteristics Reference 
E. coli DH5⍺ 
(Zymo5ɑ) 
F-φ80lacZ∆M15 ∆(lacZYA-argF)U169 deoR nupG 
recA1 endA1 hsdR17(rK- mK+) phoA glnV44 
(supE44) thi-1 gyrA96 relA1, λ– 
Zymo Research  
E. coli DH5⍺ 
pENTR221L5
L2::RBS-
PA1169 
E. coli harboring pDONR221P5P2 with 
an attL flanked, 2,070 bp fragment encoding a 12 bp 
synthetic ribosomal binding site and the 2,058 bp loxA 
ORF from P. aeruginosa PAO1, KmR 
This study 
E. coli DH5⍺ 
pUC18miniTn
7T::PBAD-
PA1169 
E. coli harboring a suicide plasmid for inserting 
arabinose-inducible PA1169 onto the P. aeruginosa 
chromosome at the attTn7 site, GmR 
This study 
P. aeruginosa 
PW3111 
MPAO1 with a transposon inserted into PA1169 
(loxA::Tn) 
[229] 
P. aeruginosa 
PW3111 
Tn7:PBAD-loxA 
MPAO1 with a transposon inserted into PA1169 (loxA; 
PW3111) and complemented with arabinose-inducible 
loxA at attTn7 site, GmR 
This study 
Plasmids Characteristics  
pUC18miniTn
7T-Gm-GW 
pUC18-miniTn7T-Gm with a Gateway destination 
cloning site, ApR, GmR, CmR 
[232] 
pTNS3 helper plasmid encoding tnsABCD, ApR [233] 
pENTR221L1
L5r:araC-PBAD 
pDONR221P1P5r with an attL-flanked, 1,192-bp 
fragment encoding the araC repressor and 
the PBAD promoter, KmR 
[234] 
pDONR221P5
P2 
Multisite Gateway donor vector with attP5 and attP2 
recombination sites, CmR, KmR 
Invitrogen 
pENTR221L5
L2::RBS-
PA1169 
pDONR221P5P2 with an attL flanked, 2,070 bp 
fragment encoding a 12 bp synthetic ribosomal binding 
site and the 2,058 bp loxA ORF from P. 
aeruginosa PAO1, KmR 
This study 
pUC18miniTn
7T::PBAD-
PA1169 
Suicide plasmid for inserting arabinose-inducible 
PA1169 onto the P. aeruginosa chromosome at the 
attTn7 site, GmR 
This study 
Primer Sequence Reference 
attB5-RBS-
loxA-F 
ggggacaactttgtatacaaaagttgccag 
aggaggatattcATGAAACGCAGGAGTGTGC  
This study 
attB2-
loxAdown-R 
ggggaccactttgtacaagaaagctgggtaCGCCCCGTCCTCTT
TCTC  
This study 
M13F (-21) GTAAAACGACGGCCAG Eurofins 
M13R CAGGAAACAGCTATGAC Eurofins 
pBAD-F ATGCCATAGCATTTTTATCC This study 
pUC18Backbo
neR01 
GGCCGATTCATTAATGCAGC This study 
PTn7R                 CACAGCATAACTGGACTGATTTC [232] 
PglmS-down      GCACATCGGCGACGTGCTCTC [232] 
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2.2.6.6 Abiotic biofilm and supernatant collection.   
P. aeruginosa strains including the tobramycin resistant clinical isolates were grown overnight in 
LB at 37°C, 220 rpm. These overnight cultures were diluted in MEM medium (without phenol 
red), to OD600 of 0.05 and plated in 96-well vinyl microtiter plates (100 μl per well) (Costar). 
Bacteria were grown for 24h at 37°C without agitation and the supernatant was collected by 
centrifugation at 4,000 rpm for 8 min and then frozen before further use in cell death and activity 
assays. For pLoxA activity assays and treatment of HBE cells, frozen supernatants were thawed 
and centrifuged at 4,000 rpm for 8 min and protein concentration was estimated by the BCA 
protein assay (Thermo Fisher Scientific). Supernatants were added to HBE cells containing fresh 
MEM medium and incubated for 20h followed by cell death assays. We believe this freeze-thaw 
step was sufficient to prevent survival of any bacteria in the supernatants (Figure 16).  In all 
experiments, control is untreated HBE cells containing media only. Overnight cultures of MJK8 
and MJK8ΔloxA were re-suspended vigorously before measuring the OD600.  CFU assay was 
performed to determine the number of bacteria/ml in the supernatants of P. aeruginosa WT, 
ΔwspF and loxA::Tn strains. For this, the supernatants were serially diluted in MEM medium 
(without phenol red), plated on LB agar plates and incubated overnight at 37°C. For biofilm 
quantification, after the removal of supernatant, biofilms were washed using deionized water to 
remove non-adherent bacteria and stained with crystal violet (41%) for 15 min at room 
temperature. Samples were washed (3x) and biofilms were resuspended in 30% acetic acid and 
quantified at OD550 as previously reported [235].  
For pLoxA imaging, biofilms were grown on glass cover slips by placing the cover slip 
vertically in 12 well plates containing WT, ΔwspF or loxA::Tn biofilm cultures. After incubation 
(37° C for 24h), the cover slips were washed with water (2 times) and fixed with 
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paraformaldehyde (2%) or glutaraldehyde (2.5%) for 30 min and then used for pLoxA staining 
or for SEM imaging.  
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Figure 16. Cell death induced by ΔwspF supernatant is not affected by presence of bacteria 
in the supernatant. 
HBE cells were treated with ΔwspF supernatant alone or with Gentamycin (20 µg/ml) in the 
presence or absence of ferrostatin-1(FER). Cells were incubated for 20h and then used for cell 
death analysis. Data represents mean±s.d., *p<0.05 vs. Control; #p<0.05 vs. ΔwspF or 
ΔwspF+Gen. N=3. 
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2.2.6.7 Biotic biofilm assay.   
HBEs were enzymatically dissociated, expanded in growth media, and seeded onto Trans-well 
inserts and grown at the air–liquid interface for 7-10 days. Cultures were used when well 
polarized and differentiated [236]. Biotic biofilm assays were performed as follows: overnight 
culture of the ΔwspF mutant strain P. aeruginosa was rinsed once and added to the apical surface 
of the epithelial cells in 500 μl of MEM with 0.4% glutamine at a multiplicity of infection (MOI) 
of 25. After the 60 min bacterial attachment period, developing biofilms were treated with 
vehicle or ferrostatin-1 (0.2 and 1.0 µM) for the subsequent 5h. At the end of this period, 
biofilms were removed with 0.1% Triton X-100 and live bacteria were plated in a CFU assay. 
2.2.6.8 Knock-down (KD) of ACSL4 and LPCAT3.  
HBE cells were transfected with a mix of two Dicer-substrate short interfering RNAs (DsiRNAs) 
against ACSL4 (mm.Ri.Acsl4.13. and mm.Ri.Acsl4.13.2) or On target plus SMART pool 
LPCAT3 si-RNA (L-010273-01-0005., Dharmacon) or with negative control DsiRNA (51-01-14-
04) (Integrated DNA Technology) using Lipofectamine 3000 (Life Technology) according to 
manufacturer’s instructions. Efficiency of KD was determined by Western blotting using 
antibodies against ACSL4 (1:1,000) and LPCAT3 (1:500). 
2.2.6.9 Live-cell imaging. 
To visualize intracellular lipid-peroxidation, HBE cells were seeded in glass-bottomed (35 mm) 
tissue culture dishes (MatTek Corp., Ashland, MA) and after 48h, cells were pre-stained with 
Liperfluo (Djindo Molecular Technologies, Inc. Rockville, MD., 10 µM) for 30 min, washed and 
then treated with supernatant collected under biofilm growth conditions from ΔwspF strain or 
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with RSL3 (200 nM).  The dish was inserted into a closed, thermo-controlled (37ºC) stage top 
incubator (Tokai Hit Co., Shizuoka-ken, Japan) atop the motorized stage of an inverted Nikon 
TiE fluorescent microscope (Nikon Inc., Melville, NY) equipped with a 60X oil immersion optic 
(Nikon, CFI PlanFluor, NA 1.43) and NIS Elements Software. Liperfluo was excited using a 
Lumencor diode-pumped light engine (SpectraX, Lumencor Inc., Beaverton OR) and detected 
using an ORCA-Flash 4.0 sCMOS camera (HAMAMATSU Corporation, Bridgewater, NJ) and 
excitation and emission filters from Chroma Technology Corp. (Bellows Falls, VT). Data were 
collected every 5 minutes for 4 hours, on approximately 10-20 cells per stage position, with 10-
15 stage positions in each of 3 separate experiments per condition. Data were analyzed using NIS 
Elements (Nikon Inc., Melville, NY).  
To monitor cell death, HBE cells were seeded in glass-bottomed partioned (35 mm) cell 
culture dishes (Griener Bio-One GmbH., Germany) and after 48h, cells were treated with ΔwspF 
supernatant in presence of Sytox Green and examined for 48h by live cell imaging. Data were 
collected every 30 min for 48h and analyzed by NIS Elements (Nikon Inc., Melville, NY). 
2.2.6.10 Western blotting.  
Total cell lysates were prepared after washing cells with PBS and then adding cell lysis buffer 
(25mM Tris-HCl, pH 7.5, 150 mM NaCl and 1% SDS) or RIPA buffer (Thermo Fisher 
Scientific) containing freshly added protease-phosphatase cocktail inhibitor mix (Thermo Fisher 
Scientific). Samples were boiled at 95°C for 10 min, sonicated to break down DNA. Total 
protein was estimated by Pierce BCA protein assay kit (23225) and diluted with 2X or 4X 
Laemmli buffer before loading in Tris-glycine gradient gels (8–16% Tris-Glycine Gels) (Life 
Technologies). Proteins were transferred to PVDF membrane (Biorad), blocked with milk (5%) 
in PBST (0.1% Tween) 1h, incubated with primary antibodies (1% BSA in PBST) overnight at 
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room temperature (RT), washed 3 times and incubated with secondary antibody (1 h) in blocking 
solution before developing with SuperSignal™ West Pico Chemiluminescent Substrate (Thermo 
Fisher Scientific). 
For analysis of GPX4, HBE cells (80,000 cells per well) were seeded in 6-well plate and 
samples were collected after 20h of treatment. Quantification of the bands was performed using 
ImageJ software from NIH (imagej.nih.gov/ij/).  
For pLoxA Western blotting, P. aeruginosa (WT, ΔwspF, loxA::Tn), MJK8 (WT and 
MJK8ΔloxA) and the clinical isolates were grown in biofilm conditions in 3 ml of MEM media 
or LB media for 24h. After centrifugation, pellet washed with PBS and then resuspended in 
RIPA lysis buffer or in Laemmli buffer (2X). Cells were lysed by freeze/thaw (3 cycles) and 
sonication (3 times, 10 sec on, 10 sec off).  Supernatants were collected after centrifugation (10 
min, 12,000 rpm) and amount of protein estimated as mentioned earlier. Samples in Laemmli 
buffer were boiled (10 min), sonicated and protein was estimated using Pierce 660 nm protein 
assay (Thermo Fisher Scientific). Equal amount of protein was loaded in Tris-glycine gradient 
gels and transferred to PVDF or nitrocellulose membranes (Biorad), blocked with BSA (2.5%) in 
PBST 2h and incubated with anti-pLoxA antibody (1:1,000)  (in 1% BSA in PBST) overnight at 
RT.  Blots were washed (3 times) and incubated for 1h with secondary antibody (1:2,000) in 
milk (5%) before developing. Bands were quantified by ImageJ software and recombinant 
pLoxA included in the gels was used to generate a standard curve and determine the amount of 
pLoxA in clinical isolates.  
2.2.6.11 Arachidonic acid supplementation.   
Arachidonic acid (AA) (Sigma-Aldrich, A0281) was added to HBE cells as reported previously 
[225]. Briefly, suspension of AA was incubated with fatty acid free bovine serum albumin (BSA 
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5%) to form a complex of AA with BSA. This soluble complex was added to and incubated with 
HBE cells overnight along with WT, ΔwspF or loxA::Tn supernatants containing 10 µg protein, 
before estimating the cell death by flow cytometry.  
2.2.6.12 Cell death assay.   
Propidium Iodide (PI) (Life Technology) staining was used to measure cell death using flow 
cytometry as described previously [225]. Briefly, HBE cells were plated in 24-well plate (12,000 
– 15,000 cells/well).  After 48h, cells in fresh media were incubated with P. aeruginosa 
supernatants containing 10 µg of protein alone or with indicated treatments for 20h.  Cells were 
trypsinized, centrifuged at 700 x g for 6 min and resuspended in PBS containing PI for 5 min on 
ice and then monitored by flow cytometry. The gate settings were chosen at 5% or less PI – 
positive cells for control samples.  Annexin V-FITC (BioVision) staining  and MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Invitrogen) cell viability assay were 
used as described previously [225]. Cell death was calculated as per instructions of the 
manufacturer. 
For ACSL4 and LPCAT3 KD samples, 12h after transfection, cells were seeded in 24 
well plates (15,000 per well) and in 6-cm tissue culture dish. After 36h, cells were treated with 
ΔwspF supernatant for 20h and cell death was analyzed by flow cytometry after staining with PI. 
Samples from 6-cm dish were used for western blotting.   
2.2.6.13 Cell death induced by genetically manipulated pLoxA 
Overnight culture of pLoxA deficient (loxA::Tn  (PW3111)) and complemented (PW3111 
Tn7::loxA) strains were re-inoculated at an OD600 of 0.05 and grown in biofilm conditions in 
presence of 0.1%  arabinose for 24h. Cultures were centrifuged and the pellet was washed with 
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PBS, then resuspended in PBS containing protease inhibitors. Cells were lysed by freeze/thaw 
method as mentioned earlier.  Cell supernatants were collected after centrifugation (10 min, 
12,000 rpm) and protein amount estimated by BCA protein assay (23225). Equal amount of 
protein (100 µg) was incubated with SAPE (100 µM), in 150 mM borate buffer (pH 9.0) 
containing 0.02% deoxycholate for 30 min at RT under constant supply of oxygen.  The reaction 
mix was added to RSL3 (20 nM) pre-treated HBE cells (4h) with or without ferrostatin-1 and 
incubated for 2h in the absence of serum. Then serum was added back to the final concentration 
of 10% and the cells were incubated for 20h before cell death measurements.  
2.2.6.14 Ferroptosis induced by exogenous 15-HOO-AA-PE 
HBE cells were pre-treated with RSL3 (20 nM) for 4h and then incubated with 15-HOO-AA-PE 
(0.75 µM) for 2h in the absence of serum. After adding back serum (10% final concentration), 
15-HOO-AA-PE sensitized cells were then treated with equal amounts of supernatant (5 µg) 
either from loxA::Tn or WT in the presence or absence of ferrostatin-1 and incubated overnight 
before cell death assays.  
2.2.6.15 GSH measurements. 
After incubations, cells were suspended in 80 µl PBS, freeze/thawed at -80°C and mildly 
sonicated on ice. For GSH analysis (run in triplicates) 15 µl of sample was incubated in PBS 
with 10 mM Thiol Fluorescent Probe IV (Millipore) for 15 min. Then fluorescence was 
measured with Cytation 5 imaging reader by using an excitation wavelength of 535 nm and an 
emission wavelength of 585 nm. Protein concentration was measured by Bradford Protein Assay 
(Bio-Rad). 
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2.2.6.16 Assessment of pyocyanin.  
UV-Vis spectra of chloroform extracts from clinical isolates were performed in the range of 300-
800 nm. The total concentration of pyocyanin was determined in chloroform extracts dried and 
re-dissolved in methanol by absorbance at 690 nm using molar extinction coefficients of 5816 
[237].  
2.2.6.17 AA and AA-PE docking to pLoxA.   
Ligand docking has been performed using the SMINA package[238], which is customized to 
better support scoring function and high-performance energy minimization.  The structure used 
for pLoxA was 4G32 [162].   Five runs each for AA and AA-PE were performed, and the top 
binding pose (lowest energy) was considered for statistical purposes.  
2.2.6.18 Sequence alignment, generation of sequence similarity map and phylogenetic 
tree construction. 
 A multiple sequence alignment (MSA) of lipoxygenase domains was downloaded from the 
Pfam protein families database [239] and analyzed using ProDy [240]. The MSA was refined by 
removal of poorly aligned and highly similar sequences, resulting in a final alignment of 218 
sequences that was more amenable to further analysis. This was followed by alignment and 
sorting of the sequences with MUSCLE [241, 242] and manually curated using UniPro UGENE 
[243]. The resulting alignment was then fed back into ProDy for additional analysis including 
production of the sequence identity matrix shown in Figure 25A. 
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2.2.6.19 Gaussian Network Model (GNM) and Anisotropic Network Model (ANM) 
analyses for protein dynamics.   
The analysis of ANM[244] and GNM[245] was done using the ProDY API.  Identification of 
relative modes of motion along the principle mode was done using GNM.   In this model, the 
positive (red) and negative (blue) regions indicate the structural regions which are subject to 
correlated (positive) or anticorrelated (negative) motions.   The theory of GNM and ANM can be 
found in [244, 245] respectively.  Movie was generated using the ANM implemented in the 
DynOmics server [246]. Structural visualization and analysis were performed using ProDy. 
2.2.6.20 Expression and purification of pLoxA. 
 pLoxA with a His6 tag was purified using NTA-Ni affinity chromatography, as described 
previously [22, 33]. Briefly, pet151/His6-pLoxA plasmid containing Escherichai coli BL21 
(DE3) was grown to OD600 of 0.6 at 37 °C and induced by incubating the culture at low 
temperature (20°C) overnight. Pellet was collected by centrifugation (5,000 x g, 10 min), 
resuspended in buffer A (25 mM HEPES (pH 7.5), 150 mM NaCl) and sonicated to lyse the 
cells.  Lysate was centrifuged at 40,000 x g for 25 min and the supernatant was loaded onto an 
NTA-Ni affinity column, washed with lysis buffer and the protein eluted with a gradient of 0 to 
500 mM imidazole in buffer A. Fractions containing pLoxA were pooled together and preserved 
in 10% (v/v) glycerol and stored at -80°C for further use.  
2.2.6.21 pLoxA antibody purification.  
pLoxA antibody against recombinant purified pLoxA was raised and purified from rabbit whole 
blood by Pocono Rabbit Farm and Laboratory as described previously [22]. Briefly, recombinant 
pLoxA (3mL of 2mg/mL) was immobilized using Pierce Aminolonk immobilization kit 
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following manufacturer’s recommendations. After loading 4 mL of rabbit serum, column was 
washed with PBS (7 mL), 1M NaCl (1 mL) and PBS (7 mL) and finally eluted with glycine (6 
mL). Fraction with more than 0.05 mg/mL of protein were pooled and stored at -80°C in 
presence of 10% glycerol.    
2.2.6.22 Liposome preparation.   
Liposomes of DOPC/SAPE (1:1) or DOPC/AA (1:10) were prepared using sonication method. 
Briefly, 1,2-dioleoyl-PC (DOPC) and 1-stearoyl-2-arachidonyl-PE (SAPE) (Avanti Polar Lipids 
Inc., Alabaster, AL), lipids were dried under nitrogen and resuspended in PBS (pH 7.4) prepared 
fresh under oxygen flow. Lipids were vortexed and then sonicated using Torbeo ultra cell 
disruptor (36180-series) with maximum power for 10 min on ice.  
2.2.6.23 Oxidation of AA and AA-PE by P. aeruginosa supernatant or pLoxA in a 
model system.  
Lipoxygenase activity of the P. aeruginosa supernatants (WT, ΔwspF and loxA::Tn) was 
assessed by formation of primary products of AA oxidation: 15-HpETE or PE (C18:0/15-
HpETE) that were detected by reverse phase LC/MS. Briefly, supernatants were incubated with 
liposomes (DOPC/AA or DOPC/SAPE) in the presence of 0.5 µM 15-HpETE, 100 µM DTPA in 
20 mM HEPES pH 7.4 at 37°C for 10 min. To prevent conversion of 15-HpETE to secondary 
products during incubation, HEPES buffer included 100 µM DTPA (for transition metals 
chelation) that has been saturated with oxygen (before addition of supernatants or pLoxA). For 
oxidation of AA-PE with purified recombinant pLoxA, 400 nM of enzyme was incubated with 
DOPC/SAPE (1:1) liposomes along with 0.5 µM 15-HpETE, 100 µM DTPA in 20 mM HEPES 
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pH 7.4 at 37°C for 10 min. At the end of incubation AA and PE as well as their oxygenated 
products were extracted by Folch [247] procedure and analyzed by LC/MS. 
2.2.6.24 Determination of pLoxA activity in P. aeruginosa clinical isolates.  
Clinical isolates (50 µl) were mixed in 1:1 ratio with 20 mM HEPES buffer pH 7.4, containing 
100 µM DTPA, 10 µM AA (arachidonic acid), 0.5 µM 15-HOO-AA-PE and incubated at 37 oC 
during 10 min. At the end of incubation AA and its oxygenated products were extracted by Folch 
procedure [247] and analyzed by LC/MS. The data were normalized to the amount of protein and 
represented as AAoxidation  (pmol/min/µg of protein).  
2.2.6.25 Redox phospholipidomics.  
MS of PLs was performed on an OrbitrapTM FusionTM LumosTM mass spectrometer 
(ThermoFisher Scientific). Phospholipids were separated on a normal phase column (Luna 3 µm 
Silica (2) 100Å, 150 x 2.0 mm, (Phenomenex) at a flow rate of 0.2 mL/min on a Dionex Ultimate 
3000 HPLC system at 35 °C. Gradient solvents A: propanol:hexane:water (285:215:5, v/v/v)  
and B: propanol:hexane:water (285:215:40, v/v/v) containing 10 mM ammonium acetate were 
used. The column was eluted for 0-23 min with a linear gradient from 10% to 32% B; 23-32 min 
from 32 to 65% B; 32-35 min from 65 to100% B; 35-62 min held at 100% B; 62-64 min from 
100% to 10% B followed by and equilibration from 64 to 80 min at 10% B. The instrument was 
operated with ESI probe in negative mode. Analysis of data was performed using software 
package Compound DiscovererTM (ThermoFisher Scientific) with an in-house generated analysis 
workflow and oxidized phospholipid database. Lipids were filtered by retention time and 
confirmed by fragmentation analysis.  
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2.2.6.26 Analysis of AA and its oxidation products.  
AA and AAox were analyzed by LC/MS using Dionex Ultimate TM 3000 HPLC system coupled 
on-line to Q-Exactive hybrid quadrupole-orbitrap mass spectrometer (ThermoFisher Scientific, 
San Jose, CA) using a C18 column (Accliam PepMap RSLC, 0.3 mm x 15 cm, ThermoFisher 
Scientific). Gradient solvents (A: Methanol (20%)/Water (80%) (v/v) and B: Methanol 
(90%)/Water (10%) (v/v)) with 5 mM ammonium acetate were used. The column was eluted at a 
flow rate of 12 µL/min using a linear gradient from 30% solvent B to 95% solvent B over 70 
min, held at 95% B from 70 to 80 min followed by a return to initial conditions by 83 min and 
re-equilibration for an additional 7 min. Spectra were acquired in negative mode with the scan 
range of 150-600 m/z, maximum injection time 100 ms and resolution of 1400,000. An isolation 
window of 1.0 Da was set for the MS and MS2 scans with an inclusion list of AA oxygenated 
products. Capillary spray voltage was set at 2.6 kV, and capillary temperature was 250°C. The S-
lens Rf level was set to 60. Analytical data were acquired and analyzed using Xcalibur software. 
2.2.6.27 Statistical analysis.   
All the data are shown as means±s.d. from at least three experiments (biological replicates) 
unless otherwise specified. Statistical analysis was performed using SPSS software 25 (IBM 
Corporation, Armonk, NY). One-way ANOVA followed by Fisher-LSD post-hoc analysis was 
used for multiple group comparisons. The threshold of significance was set at p< 0.05. Sample 
sizes (n) are indicated in the figure legends. In the box plots, the boundaries of the box represent 
1st quartile (bottom boundary) and 3rd quartile (top boundary), the band represents the median, 
and the whiskers represent the maximum and minimum values. 
For correlation analysis, first we checked if a Box-Cox transformation [248] was 
necessary to make the percent of ferroptotic cell death variable normally distributed, using 
 94 
PROC TRANSREG in SAS 9.4 software (SAS Institute Inc. Cary, NC).  It was found that the 
data could be regarded as normally distributed after being raised to the power of 0.25.  We 
studied the effect of the following factors on the percent of ferroptotic cell death: pLoxA amount, 
pLoxA activities (15LOX activity and 5LOX activity), amount of   pyocyanin in P. aeruginosa 
supernatants and GSH contents in HBE cells after treatments. First, the univariate effect of each 
factor was studied with the linear regression for the transformed percent of ferroptotic cell death. 
Variables from univariate models that had a p-value of less than 0.1 were considered for 
inclusion in the multivariate regression analysis. Then we performed the multivariate analysis, 
using the stepwise variable selection method to find a best linear regression model for this 
transformed endpoint. In the stepwise procedure, variables were removed from the model if the 
associated p-value was greater than 0.05. All p-values reported are two-sided. 
2.2.6.28 Study approval.  
All human samples were obtained from human volunteers who provided written informed 
consent prior to their participation in the study. All studies were approved by the Institutional 
Review Board (IRB) of the University of Pittsburgh (Pittsburgh, PA).  
2.2.7 RESULTS 
2.2.7.1 Biofilm-producing prokaryote P. aeruginosa utilizes pLoxA to induce ferroptotic 
death in HBE cells 
Transition of P. aeruginosa from planktonic to biofilm growth is associated with an sharp 
increase in expression of its lipoxygenase (ploxA) gene [22]. Given recent discovery of the 
leading role of human lipoxygenases (15LOX1 and 15LOX2) in triggering ferroptotic cell death 
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program [33]  we asked whether P. aeruginosa can induce ferroptosis in host HBE cells. Like 
many Gram-negative bacteria, P. aeruginosa produces and releases into the environment 
membrane vesicles containing many intracellular proteins, including pLoxA [249, 250]. These 
vesicles could be isolated as supernatants after centrifugation of growing cultures.  Given the 
high prevalence of inactivating mutations of wspF gene in CF clinical isolates and its hyper-
biofilm nature [230, 251, 252], we tested supernatant from ΔwspF mutant of P. aeruginosa 
grown in biofilm conditions as inducer of ferroptosis in HBE target cells. Supernatants from the 
ΔwspF mutant were significantly more efficient in inducing cell death preventable by a specific 
inhibitor of ferroptosis, ferrostatin-1, than WT supernatants (Figure 17A). Notably, the 
planktonic supernatants did not induce this type of cell death (Figure 18A).  By employing 
several commonly used inhibitors of alternative cell death programs - z-VAD-fmk (for 
apoptosis) [105], necrostatin-1s (for necroptosis) [253] and bafilomycin-A1 (for autophagic 
death) [254] - we investigated the nature of the death pathway triggered by the ΔwspF mutant 
(Figure 17B). In contrast to ferrostatin-1, none of the tested inhibitors revealed significant 
suppression of cell death induced by ΔwspF supernatant as evidenced by PI, MTT and 
PI/Annexin V double staining assessments (Figure 17B and Figures 18B, C and D).   
 
To test the involvement of pLoxA in ferroptotic death, we analyzed the level of the 
protein in lysates of WT, ΔwspF and loxA::Tn (PW3111)  P. aeruginosa.  Expectedly, ΔwspF 
mutant contained markedly higher levels of pLoxA than WT strain (Figure 19A). Similarly, 
larger amounts of pLoxA were found in biofilms formed by ΔwspF mutant than by WT strain 
(Figure 17C). No detectable signals were found in lysates of a pLoxA deficient loxA::Tn  
(PA1169 transposon deletion mutant, PW3111) strain which did not affect  abiotic biofilm 
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formation compared to WT parent strain [22] (Figure 17C, SEM images F & I and Figure 19B). 
To assess the oxygenase enzymatic activity, we performed liquid chromatography mass 
spectrometry (LC-MS)-based analysis of the products generated by WT, ΔwspF mutant and 
loxA::Tn mutant (Figure 17D). We employed two substrates, free AA (Figure 17D, left panel and 
Figure 19C) and AA esterified into PE (AA-PE) (Figure 17D, right panel and Figure 19D) and 
determined that the oxygenation activity of the ΔwspF mutant was more than an order of 
magnitude greater than that of the loxA::Tn mutant. Given that, the mutant devoid of pLoxA 
induced necroptotic but not ferroptotic cell death (Figure 17A and Figure 19E), we concluded 
that the presence of pLoxA is indispensable for generating pro-ferroptotic signals.  
To examine whether exogenous pLoxA in P. aeruginosa supernatants is the major 
contributor to ferroptosis in HBE cells, we studied the effects of two specific small-molecule 
inhibitors of mammalian 15LOX, PD146176 and ML351 [105, 255]. In agreement with previous 
reports [225], ferroptosis induced in HBE cells by an inhibitor of GPX4, RSL3, was markedly 
suppressed by both inhibitors (Figure 17E, left panel). In contrast, both mammalian 15LOX 
specific inhibitors, which do not target pLoxA, were inept in protecting against P. aeruginosa 
induced ferroptosis (Figure 17E, right panel). However, baicalein, a non-specific lipoxygenase 
inhibitor, suppressed cell death induced by both RSL3 and P. aeruginosa (Figure 19F).  
To further scrutinize the role of pLoxA in ferroptosis we used two genetic approaches. 
First, we generated a loxA::Tn complemented strain (PW3111 Tn7::loxA) expressing pLoxA. 
Bacterial cell lysates prepared from complemented PW3111 Tn7::loxA and pLoxA-deficient 
loxA::Tn (PW3111) strains grown in biofilm conditions were incubated with the pLoxA substrate 
– stearoyl-arachidonoyl-PE (SA/AA-PE) to generate the pro-ferroptotic signal 15-HOO-SA/AA-
PE. We added this reaction mixture to HBE cells pre-treated with RSL3 in the presence or 
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absence of ferrostatin-1. Cell lysate from pLoxA expressing complemented strain induced cell 
death which was rescued by ferrostatin-1 while lysate from pLoxA deficient strain (loxA::Tn) did 
not induce ferroptosis (Figure 17F and Figures 19G and 19H). Second we used a PAO1 isogenic 
strain - rugose small colony variant MJK8 and its loxA deleted strain MJK8∆PA1169 [230] 
(herein referred to as MJK8∆loxA). Supernatants from MJK8 strain induced cell death prevented 
by ferrostatin-1 while the MJK8∆loxA supernatant did not induce ferroptotic cell death of target 
HBE cells (Figure 17G and Figure 19I).  
 
 
Figure 17. pLoxA is required for P. aeruginosa supernatant induced ferroptosis. 
(A) HBE cells were treated with supernatants (10 µg each) from WT, ΔwspF or pLoxA deficient 
mutant loxA::Tn (PW3111) with or without ferrostatin-1 (FER, 0.2 μM). Cell death (20h) 
assessed by propidium iodide (PI); means±s.d., *p<0.05 vs. control (untreated HBE cells); 
#p<0.05 vs. corresponding no FER treatement, N=3. (B) ΔwspF supernatant alone or with z-
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VAD-fmk (20 μM), Nec-1s (20 μM), Baf-A1 (1 nM). FER, positive control; means±s.d., 
*p<0.05 vs. control (untreated); #p<0.05 vs. ΔwspF only, N=3. (C)  Representative fixed 
Biofilms on glass cover-slips stained with anti-pLoxA antibodies (Green) (B, E & H) or analyzed 
by SEM (C, F & I) (out of 3 performed)  (D) Dioxygenase activity: WT, ΔwspF or loxA::Tn 
supernatants were incubated with DOPC/AA (1:10) or DOPC/SAPE (1:1) liposomes (10 min, 
37°C). AA oxidation product, 15-HpETE (Left panel), or HpETE-PE from AA-PE (Right panel) 
assessed by LC-MS; normalized to bacteria/ml of supernatant; *p<0.05 vs. loxA::Tn supernatant, 
N=3. (E) Effect of 15LOX specific inhibitors (PD146176 and ML351; 1.0 μM) on ΔwspF-
ferroptosis. RSL3 (200 nM, left panel) was a positive control (both inhibitors were effective 
against host 15LOX); means±s.d., #p<0.05 vs. control (untreated); *p<0.05 vs. RSL3 or ΔwspF-
supernatant, N=3. (F) Bacterial cell-lysates (pLoxA deficient or complemented, 100 µg each) 
were incubated with SAPE (100 µM, 30 min) and then added to RSL3 (20 nM) pre-treated HBE 
cells with or without FER (0.2 µM).  Means±s.d.,*p<0.05 vs. RSL3; #p<0.05 vs. no FER 
PW3111 Tn7-loxA, N=3. (G) HBE cells were incubated with supernatant from MJK8 or its loxA-
knock out strain (MJK8ΔloxA) in the presence or absence of FER (0.2 µM). means±s.d., *p<0.05 
vs. control (untreated HBE cells); #p<0.05 vs. no FER MJK8 supernatant, N=3. (1-way ANOVA 
for A, B, D, E, F and G) 
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Figure 18. P. aeruginosa supernatant induced cell death is rescued by ferrostatin-1. 
(A) HBE cells were treated with P. aeruginosa WT or ΔwspF mutant supernatants (Sup.) 
collected in planktonic growth conditions in the presence or absence of a ferroptosis inhibitor, 
ferrostatin-1 (FER, 0.2 µM) for 20h at 37°C. Cell death was monitored after PI-staining by flow-
cytometry. Data represent means±s.d., N=3. (B) Representative FACS plots showing the settings 
of gating used for cell death analysis using PI-staining. Control (Left panel) and ΔwspF 
supernatant (Right panel).  (C & D) HBE cells were incubated with ΔwspF supernatants alone or 
with z-VAD-fmk (20 μM), Nec-1s (necrostatin-1s, 20 μM) or Baf-A1 (bafilomycin-A1, 1 nM). 
FER was used for comparative assessments of ferroptotic cell death (“positive control”).  Cell 
death was assessed by MTT assay (C) or PI/Annexin V double-staining (D) (Right panel). Data 
represent mean±s.d., *p<0.05 vs. control (untreated); #p<0.05 vs. ΔwspF only N=3. (D)  
Representative PI/Annexin V double staining FACS plots for control and ΔwspF supernatant 
(Left panel).    
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Figure 19. pLoxA is required for P. aeruginosa supernatant induced ferroptosis.  
(A) Expression of pLoxA in the ΔwspF mutant. Western blots of pLoxA in lysates of WT, 
ΔwspF and loxA::Tn strains from biofilm cultures (Upper panel), PP is purified pLoxA protein. 
Control is loading control PA-I lectin. (B) P. aeruginosa wild type (WT), ΔwspF mutant or 
ΔloxA::Tn (PW3111) mutant were grown in LB broth for 12-14 h at 37°C, diluted (OD600 = 0.05) 
in MEM and plated in 96-well vinyl microtiter plates  (100 µl per well). Bacteria were grown for 
24 h at 37°C without agitation, the supernatants were removed and the bofilms were washed with 
water, stained with crystal violet (41%), and quantified at OD550. Data represent mean ± s.d., 
*p<0.05 vs. WT, N = 3. (C and D) Typical LC-MS profiles of oxidized (Upper panel) and non-
oxidized (Lower panel)  AA (C) and AA-PE (D). (E) HBE cells were treated with loxA::Tn 
supernatants alone or with FER (0.2 µM), or with z-VAD-fmk (20 μM) or Nec-1s (necrostatin-
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1s, 20 μM) or Baf-A1 (bafilomycin-A1, 1 nM). Data presented are means±s.d., *p<0.05 vs. 
loxA::Tn,  N=3 (F) HBE cells were treated with ΔwspF supernatants or RSL3 in the absence or 
presence of Baicalein (5.0 and 10.0 µM) for 20 h at 37°C. Cell death was estimated by flow 
cytometry. Data represent means ± s.d., *p<0.05 vs untreated control; #p<0.05 vs. RSL3 or 
ΔwspF supernatant, N = 3. (G) Bacterial cell-lysates (pLoxA deficient or complemented, 100 µg 
each) were incubated with SAPE (100 µM) for 30 min and then added to RSL3 (20 nM) pre-
treated HBE cells with or without FER (0.2 µM). Ferroptotic cell death = Cell death induced in 
the absence of ferrostatin-1 – cell death protected by ferrostatin-1. Data represent means ± s.d., 
*p<0.05 vs. RSL3 + loxA::Tn, N = 3.  (H) Western blot shows expression of pLoxA in 
complemented strain (Upper panel). PP is purified pLoxA. Control is loading control PA-I lectin 
(Lower panel). (I) Western blot of pLoxA in lysates of MJK8 WT and MJKΔloxA using 
antibody against pLoxA. PP is recombinant pLoxA. Lower panel: Loading control PA-I-lectin. 
 102 
2.2.7.2 pLoxA generated 15-HOO-AA-PE act as pro-ferroptotic signals in HBE cells  
To interrogate the role of lipid hydroperoxides as pro-ferroptotic signals, we employed a 
fluorogenic probe, Liperfluo, which, similar to GPX4, selectively reduces hydroperoxy-lipids to 
respective alcohols to yield a fluorescent product [256, 257]. Incubation with the ΔwspF mutant 
supernatant induced a time-dependent increase in the fluorescent signal in HBE cells, which was 
fully protected by ferrostatin-1 (Figure 20A, left and right panels). This response was similar to 
the one elicited by the treatment of HBE cells with a GPX4 inhibitor, RSL3, as a positive control 
[225]. Notably, Liperfluo fluorescence originated in a single cell, over time was spreading and 
detectable in clusters of many surrounding cells (i.e., in a non-cell autonomous fashion) (Figure 
20B). Assuming that Liperfluo fluorescence responses were report the early generation and 
propagation of pro-ferroptotic lipid peroxidation products, we monitored the dissemination of 
cell death using Sytox Green labeling of HBEs. Similar to previously reported results [97, 258, 
259], P. aeruginosa ΔwspF supernatant induced cell death was also associated with the 
appearance of clusters of dying cells (Figure 21). Expectedly, this clonal loss of plasma 
membrane integrity revealed by Sytox Green occurred at later time points than Liperfluo-
positivity of cells. 
To determine the molecular identity of lipid oxidation products generated by P. 
aeruginosa ΔwspF supernatant in HBE cells, we performed quantitative phospholipidomics 
analysis (Figure 20C-E).  We established that PE contained 15 oxidized species (Figure 20D and 
Table 3). Importantly, treatment of HBE cells with ferrostatin-1 selectively reduced the levels of 
four oxidized PE (PEox) species (Figure 20E) that have been identified as PE containing either 
15-HOO-AA-PE or 12-HOO-AA-PE in sn-2 position (Figures 22 and 23)  and were previously 
reported as predictive biomarkers of RSL3-induced ferroptosis [225].  
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To further explore the role of phospholipid peroxidation in P. aeruginosa induced cell 
death, we manipulated the content and molecular speciation of lipids in target cells. Our previous 
work showed that AA-supplementation sensitizes cells to ferroptosis via increased synthesis of 
AA-PE as a pro-ferroptotic oxidation substrate for 15LOX [225]. Exogenous AA significantly 
enhanced ferroptosis induced by WT and ΔwspF supernatants but had no effect on pLoxA 
deficient loxA::Tn (PW3111) supernatant (Figure 24A). 
 Additional testing was performed by genetic manipulations of phospholipid biosynthetic 
(Acyl-CoA synthetase Long-Chain Family Member 4, ACSL4) or remodeling 
(Lysophosphatidylcholine Acyltransferase 3, LPCAT3) pathways. HBE cells with knock-down 
(KD) of ACSL4, which catalyzes the formation of long-chain PUFA-CoA (AA-CoA) [260], 
completely prevented P. aeruginosa-induced ferroptosis (Figure 24B).  Similarly, KD of 
LPCAT3, involved in re-acylation (Lands cycle) of lysophospholipids [261], also markedly 
suppressed ferroptosis in HBE cells (Figure 24B and Figure 25A).  Intriguingly, pLoxA-
dependent biofilm formation [22] and epithelial cell death are interconnected as inhibition of 
ferroptosis by ferrostatin-1 was accompanied by a two-fold growth decrease in a biotic model 
(Figure 24C).  
GPX4 can directly reduce hydroperoxy-PLs to non-pro-ferroptotic hydroxy-PLs [84, 257, 
262]. Depletion of GPX4 - critical for the development of ferroptotic response - has been 
observed in a variety of cells treated with RSL3 [84, 225, 263]. P. aeruginosa ΔwspF supernatant 
induced substantial loss of GPX4 protein in HBE cells (Figure 24D) thus eliminating this anti-
ferroptotic regulator. Due to the reduction of 15-HOO-AA-PE to 15-HO-AA-PE by endogenous 
GPX4 in HBE cells, recombinant pLoxA was unable to induce ferroptotic cell death (Figure 
25B), even though it generated 15-HOO-AA-PE in a model system (Figure 25C). However, 
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inactivation of GPX4 by RSL3, facilitated ferroptosis induced by WT but not pLoxA deficient 
loxA::Tn supernatant in 15-HOO-AA-PE-sensitized HBE cells, thus signifying the role of pLoxA 
(Figure 24E). 
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Figure 20. P. aeruginosa supernatants generate pro-ferroptotic hydroperoxy-lipid signals in 
HBE cells.  
(A) Detection of lipid hydroperoxides by live cell fluorescence imaging of Liperfluo in HBE 
cells treated with RSL3 (200 nM) or ΔwspF supernatant for 4h. Left panel shows time-course of 
changes in the fluorescence intensity from baseline. Right panel shows typical changes in 
fluorescence (out of 4 performed) in one stage position (out of 10) at three-time points (0, 2 and 
4h).  Time control used as background fluorescence changes and RSL3 as a positive control for 
ferroptosis. For statistical analysis, each stage position was counted as one data entry. (B) 
Typical Liperfluo response (out of 4 performed) to ΔwspF showing synchronized spreading of 
the oxidized lipid signal within cells. The seed point for the signaling is indicated by an arrow in 
the t=0 image, the subsequent time course shows that the signals expanded in a clonal way to 
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include multiple surrounding cells (C) Typical mass spectrum of PE molecular species in lipid 
extracts from HBE cells (out of 3 performed). (D) Volcano plots of ΔwspF biofilm supernatant 
induced changes in the levels of oxygenated PEs (log2 (fold-change), vs. significance (-log10 (p-
value) by t-test) in HBE cells in the absence (left panel) and presence (right panel) of ferrostatin-
1 (FER, 0.2 µM). Yellow, red, blue and black circles represent PE plus one, two, three and four 
oxygens, respectively. N=3. (E) Quantitative assessments of four oxygenated PE species 
(previously identified as pro-ferroptotic signals) generated in HBE cells exposed to ΔwspF 
supernatants. *p<0.05 vs. control; **p<0.05 vs. ΔwspF, (1-way ANOVA),  N=3. 
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Figure 21. Cell death induced by ΔwspF supernatants. 
HBE cells were treated with ΔwspF supernatants in the presence of Sytox Green and monitored 
for 48h by live-cell imaging. Sytox Green is a membrane impermeant nuclear dye that will only 
be seen in cells with permeable plasma membranes (which is indicative of the early stages of cell 
death processes).  Two areas in the image are selected (yellow and magenta circles) in each case 
over a 48h imaging cycle (imaging every 30 minutes) the evident cell death expands in a clonal 
way to include multiple cells within the delineated areas.  Bar=100 microns. 
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Table 3. PE-OX species identified in Human Bronchail Epithelial (HBE) cells treated with 
P. aeruginosa hyper-biofilm mutant (ΔwspF) supernatant. 
Plus 1 Oxygen Plus 2 Oxygen Plus 3 Oxygen Plus 4 Oxygen 
PE(34:2)+1O PE(34:4)+2O PE(38:4)+3O PE(38:2)+4O 
  PE(38:4)+2O PE(36:5)+3O PE(40:6)+4O 
  PE(36:5)+2O     
  PE(38:5)+2O     
  PE(36:4)+2O     
  PE(34:3)+2O     
  PE(36:3)+2O     
  PE(44:5)+2O     
  PE(38:6)+2O     
  PE(40:6)+2O     
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Figure 22. Identification of di-oxygenated PE species in HBE cells exposed to supernatants 
obtained from ΔwspF mutants. 
MS2 profiles of di-oxygenated PE species (15-HOO-AA-PE and 12-HOO-AA-PE): (A) with m/z 
798.5300 identified as 1-stearoyl-2-12-HpETE-sn-glycero-3-phosphoethanolamine (1-SA-2-12-
HpETE-PE,) and 1-steraoyl-2-15-HpETE-sn-glycero-3-phosphoethanolamine (1-SA-2-15-
HpETE-PE,) and (B)  with m/z 796.5242 identified as 1-oleoyl-2-12-HpETE-sn-glycero-3-
phosphoethanolamine (1-OA-2-12-HpETE-PE) and 1-oleoyl-2-15-HpETE-sn-glycero-3-
phosphoethanolamine (1-OA-2-12-HpETE-PE). Inserts: Structural formulae of identified 
species; (C) MS3 profiles of molecular ion with m/z 317.23 (m/z 335-H2O) formed during MS2 
fragmentation of di-oxygenated PE species with m/z 798.5300 (upper panel), m/z 796.5242 
(Lower panel). Insert: Structural formulae of identified di-oxygenated AA metabolites: 12-HOO-
arachidonic acid (12-HpETE) and 15-HOO-arachidonic acid (15-HpETE). Characteristic 
fragments used for identification of 12-HpETE and 15-HOO-AA are shown in blue and red, 
respectively. Identification was performed based on MS2 and MS3 fragmentation analysis using a 
TribridTM Ion-trap/OrbitrapTM Fusion-LumosTM mass spectrometer, (Thermo-Fisher Scientific, 
NJ). 
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Figure 23. Identification of tri-oxygenated PE species in HBE cells exposed to supernatants 
obtained from ΔwspF mutants. 
(A) MS2 profiles of tri-oxygenated PE species (1-stearoyl-2-12-hydroperoxy-5-hydroxy-
arachidonoyl-sn-glycero-3-phosphoethanolamine (1-SA-2-15-OOH-5-OH-AA-PE) and 1-
stearoyl-2-15-hydroperoxy-5-hydroxy-arachidonoyl-sn-glycero-3-phosphoethanolamine (1-SA-
2-12-OOH-5-OH-AA-PE) with m/z 814.5211. Insert: (A) Structural formulae of identified PE 
species. (B) MS3 profiles of molecular ion with m/z 351.23 formed during MS2 fragmentation of 
di-oxygenated PE species with m/z 814.5211. Insert: Structural formulae of 12-hydroperxy-5-
hydroxy-arachidonic acid (12-OOH-5-OH-AA) and 15-hydroperxy-5-hydroxy-arachidonic acid 
(15-OOH-5-OH-AA). Identification was performed based on both MS2 and MS3 fragmentation 
analysis using a TribridTM Ion-trap/OrbitrapTM Fusion-LumosTM mass spectro-meter. 
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Figure 24. P. aeruginosa induced ferroptosis is affected by manipulations of phospholipids 
in HBE cells.  
(A) Exogenous AA enhances PA induced ferroptosis. HBE cells were treated with WT, ΔwspF  
or loxA::Tn supernatant (Sup.) alone or in combination with arachidonic acid (AA, 2.5 μM) for 
20h at 37°C. Cell death was estimated as mentioned before. Data are presented as means±s.d.; 
*p<0.05 vs. control (untreated); #p<0.05 vs. corresponding supernatant only; $p<0.05 vs. 
corresponding AA treatment. N=3. (B) HBE cells were transfected with scrambled si-RNA (si-
NC) or si-RNA against ACSL4 or LPCAT3. Transfected cells were treated with ΔwspF 
supernatants with or without ferrostatin-1 (FER 0.2 μM) for 20h at 37°C before estimating cell 
death. Data are presented as means±s.d.; *p<0.05 vs. si-NC ΔwspF, N=3. (C) Ferrostatin-1 
inhibits P. aeruginosa induced biofilm formation on HBE cells. Polarized HBE cells were 
incubated with ΔwspF P. aeruginosa (MOI of 25) for 1h. After washing unattached bacteria, 
HBE cells in the absence or presence of ferrostatin-1 (0.2 and 1.0 μM) for 5h. Biofilms were 
removed, lysed with Triton X-100 (0.1%) and the number of bacteria in each sample was 
determined by CFU assay. Data are presented as means±s.d.; *p<0.05 vs. ΔwspF with no FER, 
N=3. (D) Treatment of HBE cells with ΔwspF supernatant decreases the content of GPX4. Cells 
were treated with ΔwspF supernatant and incubated for 20h at 37°C. Samples were collected and 
processed for Western blotting to determine the levels of GPX4. RSL3, a covalent GPX4 
inhibitor, was used as a positive control. For quantification, the band intensity of GPx4 protein 
was normalized to respective band intensity of actin. Inset: Typical western blot (out of 3 
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performed). Data are presented as means±s.d.; *p<0.05 vs. control (untreated) HBE cells, N=3. 
(E) Exogenous 15-HOO-AA-PE elevated WT, but not loxA deficient loxA::Tn supernatant 
induced cell death. HBE cells pre-treated with RSL3 (20 nM for 4h), were incubated with 
PEOOH alone or with supernatant from loxA::Tn or WT in presence or absence of ferrostatin-1 
(FER, 0.2 µM). Data are presented as means±s.d.; *p<0.05 vs. control (untreated) HBE cells, 
#p<0.05 vs. FER, N=3. (1-way ANOVA) 
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Figure 25. P. aeruginosa induced ferroptosis is affected by manipulations of (phospho)lipids 
in HBE cells. 
(A) HBE cells were transfected with siRNA negative control (NC) or siRNA against ACSL4 or 
LPCAT3 for 12h. Transfected cells were trypsinzed and plated in 6-cm culture dish. After 50h, 
samples were collected and processed for Western blotting using anti-ACSL4 and anti-LPCAT3 
antibodies. (B) HBE cells (untreated controls) or incubated with recombinant purified pLoxA 
(10.0 µg) only or pLoxA plus loxA::Tn supernatant for 20h at 37°C. Cell death was estimated 
using flow cytometry. Data represent means±s.d., N=3.  (C) Accumulation of 15-HOO-AA-PE 
species in DOPC/AA-PE liposomes catalyzed by pLoxA. (Left panel) Typical LC-MS profiles of 
oxidized (Upper panel) and non-oxidized (Lower panel) AA-PE and MS2 of oxidized AA-PE are 
shown. Possible formula of oxidized AA-PE is inserted.  (Right panel) Quantitative assessment 
of 15-HOO-AA-PE molecular species. Data represent means±s.d., N=3.   
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2.2.7.3 Computational analysis identifies evolutionarily conserved specific features of 
pLoxA required for AA-PE oxidation. 
Lipoxygenases are found in different domains of life where their activities are associated with 
vitally important functions such as differentiation, proliferation, contractility [19, 226]. 
Mammalian and bacterial lipoxygenases show little sequence identity. Alignment of pLoxA 
sequence against the structurally resolved mammalian sequences (15LOX1 from human and 
15LOX2 human) (Figure 26A) yielded respective fractional sequence identities of 0.25 and 0.31 
(note that 15LOX1 and 15LOX2 themselves also share only 36% sequence identity). 
Phylogenetic analysis of Pfam [239] family members revealed that bacterial LOXes diverged 
from those of animals and plants at approximately the same time as the animal and plant 
lipoxygenases diverged from each other (Figure 27A, left panel). The bacterial LOXes however 
seem to be more similar to animal and plant lipoxygenases than to lipoxygenases from other 
eukaryotes (e.g., fungi), suggesting that there might have been a gene transfer event since the 
prokaryote/eukaryote split and the development of multicellular organisms (Figure 27A, left 
panel). This is further illustrated by the phylogenetic tree which shows clustering of sequences 
from particular organisms. Bacteria are spread over the tree although there is a main group that 
includes pLoxA (Figure 26B). Alignment of the conserved structural core of pLoxA revealed 
223 bacterial sequences (out of ~30,000 examined) sharing a sequence identity of 20% or more 
and out of these, 37 had greater than 55% sequence identity with pLoxA.  Figure 28 displays 
their pairwise sequence identities (Figure 28A), and the corresponding phylogenetic tree (Figure 
28B). The tree reveals discrete clusters of pathogenic bacteria, including a large cluster that 
groups the Pseudomonas (green) in close proximity to Burkholderia (blue), in accord with a 
previous analysis [227]. Further examination of the location of conserved residues on the LOX 
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structure confirmed the tendency of core residues, near the catalytic site, to be conserved; 
whereas peripheral regions, including a helical hairpin that distinguishes P. aeruginosa from 
mammalian 15LOX1 and 15LOX2, exhibited significant sequence dissimilarity (or specificity) 
(Figure 28C). 
Similar to other LOX enzymes, pLoxA employs non-heme coordinated iron (Fe) for the 
dioxygenase catalysis [162]. Therefore, we assessed the level of conservation of LOX amino 
acids, with peaks indicating the most conserved residues (Figure 27B).   Expectedly, the catalytic 
site residues (H377, H382, H555, and N559 in pLoxA) were noted among the peaks. 
Examination of their evolutionary patterns across species confirmed their high level of 
conservation (Figure 27A, middle panel); whereas residues involved in substrate recognition 
exhibited a moderate level of conservation, with species-specific evolutionary trends (Figure 
27A, right panel). 
As an opportunistic bacterial pathogen, P. aeruginosa has acquired multiple adaptive 
genes favoring the highly adaptive phenotypes required to thrive and out-compete many other 
species in the highly pro-inflammatory environment of the host [160, 264, 265]. Among them is 
expression of pLoxA that facilitates the transition from planktonic to biofilm-forming state in the 
presence of the airway epithelium [22]. Utilization of secreted pLoxA to execute theft-ferroptosis 
via generation of 15-HOO-AA-PE signals not only destroys the epithelial barrier but may also 
compromise the immune-stimulating functions. To fulfill these important functions, P. 
aeruginosa has developed an enzyme with structural features distinct from mammalian (human) 
15LOX1 [15] and 15LOX2 [16] (Figure 27C). pLoxA has two C-terminal α-helical hairpin, 
composed of helices α2a and α2b, which are absent in the mammalian 15LOXs. The C-terminal 
helical hairpin modifies the organization of a ligand-binding pocket near the catalytic site 
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favoring the binding of bulky substrates, like AA-PE [162]. On the other hand, it lacks the N-
terminal β-barrel domain typical of mammalian and human 15LOXs [15]. The remaining 
portions of the structure are closely superimposable between pLoxA and mammalian LOXs 
(Figure 27C). Dynamic motions of the two α-helices modify the organization of the catalytic site 
favoring the binding of bulkier substrates, like AA-PE, vs. free AA in pLoxA (Figure 29A). 
Gaussian network model (GNM) analysis of pLoxA unveiled an additional regulatory 
mechanism whereby these helices act as a lid, regulating closed and opened states of the catalytic 
site for substrate binding (Figure 27D, upper panels). The mechanical role played by this extra 
lid is that it recruits the adjacent α2 helix of pLoxA to enable a local hinge bending mechanism, 
which in turn facilitates the binding of PE-esterified AA to a site (Figure 29A and B) in the 
vicinity of the catalytic site, just like PEBP1 in PEBP1-15LOX complex (Figure 27D, lower 
panels). 
 117 
 
Figure 26. Evolutionary analysis of LOX sequences. 
(A) Alignment of three sequences (two mammalian and the P. aeruginosa) obtained using 
Clustalx. Conserved residues are highlighted; those involved in AA binding are indicated. (B) 
Phylogenetic tree (undirected graph) obtained from the sequence-comparison map presented in 
Figure 27A. 
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Figure 27. Evolutionary analysis and computational modeling of pLoxA sequence and 
structure. 
(A) Comparing sequences of LOX homologs. The panels display sequence identity matrices 
obtained from 218 LOX sequences from all domains of life. High sequence similarity is in red, 
intermediate in yellow/green, and low in blue. Matrix generated for the entire LOX sequence 
(left panel) shows blocks evident for plants, animals and bacteria indicating their divergence a 
long time ago. Light blue shading between these blocks indicates a degree of sequence similarity 
higher than to the block of other eukaryotes at the bottom (dark blue off-diagonal). High 
conservation for the catalytic site is in the middle panel. Residues involved in substrate 
recognition (right panel) exhibit a moderate level of conservation and species-specific 
differentiation, evidenced by the blocks for plants, animals or bacteria. (B) Conservation 
propensity of LOX. The ordinate displays the Shannon entropy, subtracted from maximum 
entropy, plotted as a function of residue index; the peaks represent the most conserved residues. 
Note that catalytic residues (labeled) are among them. Residues involved in ligand coordination 
are indicated by the black dots. (C) Structural comparison of pLoxA and mammalian LOXs - 
15LOX1 and 15LOX2. The structures resolved for pLoxA (yellow ribbon), 15LOX1 (green) and 
15LOX2 (blue) are superimposed and display the missing β-barrel of the bacterial pLoxA and its 
additional α-helical hairpin motif at the C-terminus. (D) Comparison of the global motions of 
pLoxA and 15LOX1 complexed with PEBP1. Displacements of residues along the global mode 
axis obtained from GNM analysis of pLoxA (left, top) and 15LOX1-PEBP1 complex (left, 
bottom) dividing the structure into two domains that exhibit anti-correlated motion (above and 
below the dashed line). Residues at the cross-over region (hinge centers or anchors) are labeled. 
The anti-correlated groups of residues are shown in red or blue (right top and bottom).  
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Figure 28. Evolutionary analysis of lipoxygenases (comparable to pLoxA) among bacteria. 
(A) The panel displays the pairwise sequence identity matrix derived from the MSA of 223 
bacterial lipoxygenases. High sequence identity is shown in brown/red/orange, intermediate 
similarity in yellow/green, and low identity in blue. (B) Phylogenetic tree based on panel A. 
High sequence identity groups are colored: Pseudomonas (green), Burkholderia (blue), Nocardia 
(red) and Sphingomonadales (orange). (C) pLoxA crystal structure color-coded by percent 
sequence similarity (using BLOSUM100) among bacterial sequences. Regions showing 
relatively conserved sequences are in blue, those with intermediate sequence similarity are white, 
and low sequence similarity, red. 
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Figure 29. Computational modeling of pLoxA structure and molecular dynamics. 
(A) Close up view of the binding pose and coordinating residues for the two ligands, Binding of 
AA (left) panel and AA-PE (right) panel illustrate the difference between the two poses. In the 
AA-PE binding more ligand-protein interactions are seen, especially between the PE head-group 
and the protein, which are not present in the AA binding. The average energies indicate AA-PE 
binding is more efficient than AA to PLoxA. The closest distances between some ligand and 
protein atoms are indicated and labeled.  (B) Location of ligand-binding site in the structure, and 
comparison of a pair of Arg-Phe, represented by both bacterial and mammalian LOXes. 
 122 
2.2.7.4 Redox phospholipidomics reveals elevated levels of 15-HOO-AA-PE in airway 
tissues of P. aeruginosa infected patients with cystic fibrosis. 
Chronic biofilm-based infections of the airways with P. aeruginosa occur in 70–80% of patients 
with CF, representing the leading cause of morbidity and mortality in these patients [136, 137]. 
Assuming that P. aeruginosa-associated pathogenic mechanisms include pLoxA to regulate host-
pathogen interactions at the airway mucosal surface via the induction of ferroptotic cell death as 
one of the virulence factors, we performed quantitative redox phospholipidomics studies of 
airway samples from CF and non-CF patients (Figure 30A). Several oxygenated PE species were 
elevated in CF vs. control samples (Figure 31A and Table 4). We identified three PEox species 
whose levels were significantly higher in CF patients vs. non-CF controls (Figure 31B). MS/MS 
fragmentation analysis identified PE(36:4) (Figure 31C) and PE(36:5) (Figure 31D) as 
precursors of the PE oxidation products (Figure 31E). These PEox species were also present in 
P. aeruginosa treated HBE cells (Figure 20E) and have been reported as predictive pro-
ferroptotic biomarkers [225]. Microbiological testing revealed that out of 10 CF samples, 6 were 
infected with P. aeruginosa (Table 5).  Remarkably, the content of these three PEox pro-
ferroptotic signals were specifically elevated in P. aeruginosa infected CF lung samples but not 
in the samples infected with other pathogens such as Burkholderia cenocepacia, Achromobacter 
xylosoxidans or Mycobacterium abscessus (Figure 31B and Table 5).  
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Figure 30. P. aeruginosa clinical isolates from patients with persistent lower respiratory 
infection induce ferroptosis. 
(A) Typical mass spectrum of PE from a patient with CF. (B) Representative Western blot of 
clinical isolates. Samples were prepared from clinical isolates grown under biofilm conditions 
and probed with anti-pLoxA antibody (Upper panel) or stained with Ponseau S (Lower panel). 
(C) Dependence of the ferroptotic death of HBE cells on the 5LOX activity of clinical isolates 
(n=29) and (D) the contents of pyocyanin in the supernatants of clinical isolates (n=29).   
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Figure 31. Redox phospholipidomics reveals pro-ferroptotic oxygenated PE species in 
airway tissue samples from patients with cystic fibrosis (CF). 
(A) Volcano plot of differences in the levels of PEox species in CF vs. non-CF patients - (log2 
(fold-difference) vs. significance (-log10 (p-value)). Airway tissues from patients with 
emphysema were used as controls. Yellow, red, blue and black circles represent oxidized PE 
species containing one, two, three or four oxygens, respectively. N=10 (B) Quantitative 
assessments of PEox species. Non-CF samples (N=10), CF samples with P. aeruginosa (N=6), 
CF samples with other bacterial pathogens (B. cenocepacia or A. xylosoxidans and M. abscessus, 
N=4). (C-E) MS/MS-based identification of PEox molecular species in samples from patients 
with CF. Typical MS2 spectra of PEox precursors with m/z 738.5 (PE16:0/20:4) (C) and 736.5 
(PE16:1/20:4) (D) containing arachidonic acid (C20:4 at m/z 303.2) at sn-2 positions. MS2 
spectra of PEox with m/z 770.5 (PE16:0/20:4+2O) containing oxygenated arachidonic acid 
(C20:4+2O at m/z 335.2) (E) formed from the PE species with m/z 738.5 plus two oxygens (out 
of 3 performed). (F)  Tobramycin resistant P. aeruginosa clinical isolates (TRPA002-0022) from 
patients with persistent lower respiratory infection induce ferroptosis. Biofilm supernatants from 
P. aeruginosa isolates incubated with HBE cells±ferrostatin-1 (FER, 0.2 μM). Ferroptosis was 
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calculated by subtracting from cell death induced by supernatants the cell death in the presence 
of ferrostatin-1. Ferroptotic activity of clinical isolates correlated significantly with pLoxA 
amounts (determined by Western (N=29) (G), displayed strong positive dependence on 15LOX 
activity (H) (p=0.0036) and correlated negatively with GSH level of HBE cells after treatment 
(I). (J) 3D-plot illustrating jointly predicted ferroptotic activity of 15LOX activity and GSH 
(N=29). N is number of samples. (1-way ANOVA). 
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Table 4.  Identification of PE-OX species in CF lung samples infected with P. aeruginosa. 
Plus 1 Oxygen Plus 2 Oxygen Plus 3 Oxygen Plus 4 Oxygen 
PE(36:3)+1O PE(34:3)+2O PE(38:5)+3O PE(40:2)+4O 
PE(36:4)+1O PE(36:4)+2O PE(40:8)+3O PE(40:7)+4O 
PE(38:2)+1O PE(36:5)+2O PE(42:4)+3O   
PE(40:2)+1O PE(38:4)+2O     
PE(42:4)+1O PE(38:7)+2O     
PE(42:5)+1O PE(40:7)+2O     
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Table 5. Identification of Pathogenic bacteria present in CF lung samples 
S. No.  Sample Name Pathogenic bacteria 
1 CF237 Achromobacter xylosoxidans 
2 CF241 Pseudomonas aeruginosa 
3 CF242 Pseudomonas aeruginosa, Stenotrophomas maltophilia 
4 CF244 Burkholderia cenocepacia 
5 CF245 Mycobacterium abscessus 
6 CF246 Pseudomonas aeruginosa 
7 CF247 Pseudomonas aeruginosa 
8 CF248 Pseudomonas aeruginosa 
9 CF249 Pseudomonas aeruginosa 
10 CF250 Burkholderia cenocepacia 
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2.2.7.5 High prevalence of pLoxA in ferroptosis-inducing clinical isolates of P.  aeruginosa 
from persistent lower respiratory tract infection patients.   
P. aeruginosa is one of the leading opportunistic pathogens that causes healthcare-associated 
lower respiratory tract infections including ventilator-associated pneumonia (VAP) [266].  
Lower respiratory tract infections disproportionately affect the elderly, the immunocompromised 
and critically ill patients. High mortality rates associated with lower respiratory tract infections 
are further invigorated by increasing number of multi-drug and extensively-drug resistant strains 
of P. aeruginosa that leads to treatment failures and persistence of infection [267, 268].  To 
assess the significance of pLoxA in persistent lower respiratory tract infection, we examined the 
effectiveness of tobramycin-resistant P. aeruginosa respiratory isolates from 29 patients in the 
intensive care unit (ICU) to trigger ferroptosis in HBE cells (Figure 31F). We found that the 
ferroptotic cell death of P. aeruginosa clinical isolates correlated positively with the amounts of 
pLoxA (Figure 31G and Figure 30) and pLoxA enzymatic activity, particularly 12,15LOX 
activity (Figure 31H) and not significantly with 5LOX activity (Figure 30C). These data are 
compatible with our findings of 12- and 15-HOO-AA-PE dominating among the PE oxidation 
products generated by the ΔwspF mutant P. aeruginosa supernatants in HBE cells (Figures 22 
and 23).  We also found a strong negative correlation between the amounts of GSH in HBE cells 
(incubated with clinical isolate supernatants for 20h) and percent of ferroptotic cell death 
induced by clinical isolates (p<0.0001) (Figure 31I). This is compatible with the important role 
of GSH as the source of reducing equivalents for the GPX4-catalyzed reaction of elimination of 
pro-ferroptotic 15-HOO-AA-PE (via their reduction to 15-HO-AA-PE). Further, assessment of 
pyocyanin in the isolates revealed no correlation between its content and the effectiveness to 
cause ferroptosis in HBE cells (Figure 30D). Finally, we used the stepwise variable selection 
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method to generate a multivariate model and we found that 15LOX activity of pLoxA and the 
GSH amount of HBE cells jointly predicted the ferroptotic cell death with a R of 0.831 (Figure 
31J). 
2.2.8 Discussion 
Execution of ferroptotic death program has been demonstrated in multiple normal and cancerous 
mammalian cells and different tissues where it has been implicated in pathogenesis of chronic 
and acute diseases such ischemia-reperfusion of liver [269], acute kidney injury [98], and 
Parkinson’s disease [94]. Ferroptosis has been also documented in plants [270]. Here, we report 
for the first time, that ferroptotic death can be initiated by a common Gram-negative bacterial 
pathogen, P. aeruginosa that expresses and uses pLoxA to damage bronchial epithelial cells. The 
detection of pLoxA in P. aeruginosa in the early 2,000s created an apparent paradox: this 
organism does not contain PUFA lipids, the substrates of pLoxA catalyzed reactions. Overall, 
with the exception of several representatives of marine bacteria, mostly from the Shewanella spp. 
[140], the prokaryotic bacteria do not synthesize and usually do not contain PUFA lipids [140, 
228]. This in turn justifies the lack of bacterial PUFA metabolizing enzymes and respective 
genes in their genomes [228]. Intriguingly, some bacteria – including P. aeruginosa, contain 
several genes/enzymes of PUFA metabolism [160] . These include enzymes of PUFA 
oxygenation and their subsequent strictly regulated conversion into different biologically active 
metabolites [160].  
From phylogenetic studies of bacterial lipoxygenases, it can be assumed that nature 
selected P. aeruginosa to acquire lipoxygenase (pLoxA) to successfully assist its metabolic 
diversity (adapted to grow in partial or total lack of oxygen) [271] and ubiquitous presence (soil, 
 130 
water, all man-made environments, plants, animals and humans) [272, 273]. This interpretation 
is compatible with the demonstrated enhanced expression and secretion of pLoxA during biofilm 
growth of the pathogen [22]. This facilitates the pLoxA’s theft-ferroptotic mechanism as a 
virulence factor rather than membrane stabilizing enzyme [227, 228]. Transition to biofilm 
growth enables traits of multicellular lifestyle and “group behavior” which aid P. aeruginosa to 
thrive in hyper-inflammatory CF environment, resist antibiotic treatments and evade both arms 
of host immune responses [137, 274]. The switch from planktonic to biofilm growth is 
accompanied by multiple but critical changes like development of mucoid phenotype [275], 
auxotrophy [276], adapted metabolism, reduction of acute  virulence factors and expression of 
new ones [136, 277], high mutation rate [278] and antibiotic resistance [274, 279, 280].  
While pLoxA retains the major organizational principles essential for non-heme Fe-
catalysis of dioxygenation of PUFA lipids present in many mammalian and human 15LOXes, it 
also acquired several specific features unique for the role of P. aeruginosa as a bacterial 
pathogen [21, 162].  pLoxA lacks the α-barrel, which is typical of mammalian 15LOXes. The β-
barrel is substituted in pLoxA by two α-helices forming a lid, which presumably participates in 
substrate binding to the catalytic site via regulatory open and closed states of the protein. This 
function of the lid helices may be akin to the proposed role of a separate regulatory protein, 
PEBP1[33], in human 15LOXs. This helical hairpin region exhibits low sequence identity among 
bacterial LOXes, suggesting that the observed pathogenic (or pro-ferroptotic) behavior may be 
specific to P. aeruginosa. Consistently, our LC-MS analysis of clinical samples revealed 
elevated levels of pro-ferroptotic 15-HOO-AA-PE products only in cystic fibrosis patients 
infected with P. aeruginosa but not by other pathogens having similar to pLoxA sequences in 
their genomes.  
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The ability of P. aeruginosa pLoxA to act as a generator of signals for programmed death 
to host lung epithelial cells is in line with our previous data on the capacity of exogenous 
mammalian 15LOX2 + PEBP1 to trigger ferroptosis in GPX4-deficient target cells [33]. 
Combined, these results provide evidence for the importance of 15LOX-driven PE oxidation as 
pro-ferroptotic mechanism. We demonstrate that pLoxA can selectively and specifically oxidize 
membrane phospholipids, particularly AA-PE, of host epithelial cells and produce 15-HOO-AA-
PE acting as pro-ferroptotic signals which, in the absence of GPX4 activity, cause ferroptosis. 
We demonstrate that pLoxA can selectively and specifically oxidize membrane phospholipids, 
particularly AA-PE, of host epithelial cells and produce 15-HOO-AA-PE acting as pro-
ferroptotic signals. We also show that expression of pLoxA and pro-ferroptotic activity are 
associated with the pro-biofilm growth conditions of P. aeruginosa, the major pathogen in CF.  It 
is plausible to envisage the secretion of pLoxA in vesicles as a pathogenic strategy adopted by P. 
aeruginosa to deliver pLoxA into host cells [250]. Once inside, it initiates lipid oxidation and 
generation of pro-ferroptotic phospholipid hydroperoxide signals. It is also possible that 
accessible AA-PE of ferroptotically dying cells may be utilized by secreted pLoxA as the 
substrate for the production of the pro-ferroptotic signals. Therefore, once formed, the signals 
can propagate from cell to cell in a non-cell-autonomous fashion.  
In the lung of CF patients, once P. aeruginosa biofilm-based chronic infection is 
established, it is virtually impossible to eradicate it, and the infection is associated with increased 
mortality and morbidity [281].  Similarly, in P. aeruginosa nosocomial infections, a current 
worldwide healthcare issue [267], it can grow as biofilms on abiotic and biotic surfaces, resist 
antibiotic treatments and favor emergence of multi-drug resistant strains.  Here we show that the 
role of pLoxA in the pathogenesis of P. aeruginosa during more persistent biofilm growth is 
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critical. pLoxA-driven oxidation of accessible AA-PE (inside or outside of injured target cells) 
yielding 15-HOO-AA-PEs as cell death signals propagates in non-cell autonomous fashion 
spreading among the neighboring cells and allowing for enhanced lung colonization. It is 
possible that this phenomenon of P. aeruginosa induced synchronized death of host epithelial 
cells may produce: i) essential building blocks for the biofilm formation, hence enhanced 
colonization by the pathogen; ii) clusters of dying epithelial cells may impair its barrier functions 
thus causing increased vulnerability of host tissues to other injurious factors (e.g., in cystic 
fibrosis, sepsis). Collectively, the clinical data from CF-patients and P. aeruginosa ICU 
respiratory isolates strongly suggest ferroptosis as vital feature of P. aeruginosa pathogenesis 
and that pLoxA is indispensable for this process. Based on these findings, we propose that the 
development of new specific small molecule pLoxA inhibitors may lead to novel therapies 
against CF and persistent lower respiratory tract infections. This is particularly important as we 
demonstrated inefficiency of selective mammalian 15LOX inhibitors in protecting against P. 
aeruginosa induced ferroptosis. 
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3.0  SUMMARY AND FUTURE DIRECTIONS 
In the first part of the thesis, we established a genetic model of the yeast S. cerevisiae, which 
expresses H. brasiliensis ∆12-desaturase allowing it to generate PUFAs. Utilizing this model, we 
tested the hypothesis that the function of CL remodeling is to eliminate CLox species. We 
quantified CL and CLox in wild-type and cld1Δ yeast expressing the desaturase by redox 
phospholipidomics. CLox was found in both desaturase-expressing yeasts without the presence 
of exogenous oxidants. We also suggested that the major oxidation events occurred in 
mitochondria. The knockout of cld1 resulted in an increase in mono-hydroperoxy-CLs, and a 
decrease in oxidizable CLs, along with a decrease of their chronological life span, respiratory 
capacity, and mitochondrial membrane potential. In addition, the expression of cld1 was 
increased by H2O2 treatment, and in vitro experiments showed that Cld1 preferably deacylates 
the oxidized aliphatic chains in CLs. To summarize, this study suggested that the function of CL 
remodeling is to mitigate CL peroxidation and the potential adverse effects of CLox products in 
the yeast S. cerevisiae. 
Lipid peroxidation and its secondary metabolites have been reported to be involved in the 
cell death in mammalian cells. Indeed, CL oxidation and its oxidizing enzyme cyt C have been 
shown to be essential initiators of the early onset of apoptosis [71]. Furthermore, higher 
concentration of 4-HNE have been shown to induce apoptotic cell death and necrotic cell 
death[14]. Recently, hydroperoxy-PE has been identified as death signals for ferroptotic cell 
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death [90]. However, only a few studies have been conducted on the lipid peroxidation in yeast 
cell death. Lipid peroxidation was reported in yeast cells undergoing rapamycin-induced 
autophagy and H2O2 treatment [282, 283]. Lipid peroxide and 4-HNE are toxic to yeast and the 
latter induces cell cycle arrest [284, 285]. Notably, Bax-induced cell death in the yeast is 
dependent on mitochondrial lipid peroxidation, and the lipid peroxidation is poorly related to 
superoxide and H2O2 accumulation. These results suggest that possible oxidants are either 
oxygenases or secondary lipid peroxidation products [286]. Therefore, one of the future 
directions will be focused on the identification of the main contributor of lipid peroxidation in 
the desaturase-expressing yeast. Additionally, the deletion of yca1, a gene which encodes 
metacaspase that regulates yeast apoptotic cell death, can decrease the oxidative stress and 
prolong the yeast lifespan but not fully. These results suggest that PUFA-induced cell death 
occurs via both caspase-dependent and -independent mechanisms [126].  As an extension of 
these findings, one future study would be to investigate whether a caspase-dependent or -
independent form of cell death is involved in the desaturase-expressing yeast, and to further 
explore the role of yca1.  Finally, the role of CL remodeling in mitigating CL peroxidation could 
be further investigated in the study of CL remodeling defects in Barth syndrome.       
In the second part of the thesis, we studied “theft-ferroptosis” induced by P. aeruginosa 
pLoxA in human bronchial epithelium cells, and further evaluated its clinical significance. We 
found pLoxA is required for P. aeruginosa supernatant-induced ferroptosis. By applying redox 
phospholipidomics we quantified and identified pro-ferroptotic lipid signals of 15-hydroperoxy-
AA-PE in P. aeruginosa supernatant-induced ferroptotic HBE cells. Manipulation of host PL 
biosynthetic and remodeling pathways and supplementation of AA affected P. aeruginosa 
supernatant-induced ferroptosis. Evolutionary and computational analysis of pLoxA and other 
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LOX homologs showed that the catalytic core is highly conserved in all domains of life. In 
advance, the mechanism of pLoxA utilizing the α-helical-lid interaction to control the 
accessibility of PL substrates is similar to the mammalian PEBP-15LOX complex. Redox 
phospholipidomic analysis revealed pro-ferroptotic lipid signals in airway tissue samples from 
CF patients with P. aeruginosa infection but not with other pathogens. P. aeruginosa clinical 
isolate-induced ferroptosis in HBE cells was correlated with pLoxA amount and its 15LOX 
activity.  Taken together, our study showed that P. aeruginosa utilizes host polyunsaturated PE 
to trigger ferroptosis in the human bronchial epithelium. 
The understanding of the advantages of pLoxA in P. aeruginoa infection is still not 
complete. Previous studies showed that pLoxA converts AA into 15-H(p)ETE [20-22]. It has 
been known that 15-HETE can be readily transformed into lipoxins by infiltrating 
polymorphonuclear cells expressing 5LOX [287]. Another study also showed the existence of 
lipoxin synthase activity in pLoxA [21]. These studies pointed out that one of the biological 
significances of pLoxA in P. aeruginosa infection is to downregulate host inflammatory 
responses, which could increase the chance of P. aeruginosa colonization. However, unlike other 
airway pathogens, P. aeruginosa survives in hyperinflammation state in CF airways [288]. In 
contrast to the potential anti-inflammatory role of pLoxA, P. aeruginoa secretes epoxide 
hydrolase Cif to impair the resolution of inflammation and promotes pulmonary inflammation in 
CF patients [160]. Therefore, it is suggested that P. aeruginosa distinctly possesses both pro-
inflammatory and anti-inflammatory strategies to interfere host inflammation and to increase its 
survival in host airway. 
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 pLoxA was found to be required for the biofilm formation on human airway epithelial 
cells but not on an abiotic surface [22]. Given the fact that the biofilm formation increases the 
virulence and antibiotic resistance of P. aeruginosa [289], pLoxA is a potential strategic enzyme 
of P. aeruginosa for better invasion of the host. This hypothesis is also supported by the 
observation that pLoxA is able to induce hemolysis of human red blood cells in vitro [34]. Our 
findings suggest that pLoxA-induced ferroptosis is another invasion strategy of P. aeruginosa, 
possibly by damaging the epithelial barrier of the host, or by providing the essential building 
blocks to facilitate biofilm formation. Defining how ferroptosis benefits the colonization and 
invasion of P. aeruginosa in the host in vitro and in vivo will be a potential future study.          
To conclude, the first part of the thesis expanded our knowledge of CL remodeling via its 
role in removing CL peroxidation products and suggested the potential adverse effect of CLox 
species in the yeast S. cerevisiae. The study also provided a powerful genetic model for future 
studies of CL metabolism and CL peroxidation. The second part of the thesis revealed that P. 
aeruginosa hijacks and oxidizes host PUFA-lipids by pLoxA, and induces “theft-ferroptosis” in 
human bronchial epithelium. The results also emphasized the biological significance of pLoxA 
in host-pathogen interactions. Moreover, we identified a potential target for the future therapeutic 
development against P. aeruginosa-related diseases. Overall, combined with quantitative redox 
phospholipidomics, genetic, pharmacological, and computational approaches, our studies provide 
a deeper understanding of how organisms lacking PUFA synthesis utilize lipid peroxidation as 
signals. Finally, our studies also showed how an organism’s evolution and adaptation to the 
environment allowed them to further survival and propagate.      
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